{
  "disease": "glioblastoma",
  "original_target": "EGFR",
  "failed_trials_count": 8,
  "failure_patterns": {
    "safety_issues": 1,
    "efficacy_issues": 0,
    "recruitment_issues": 2,
    "business_reasons": 3,
    "other_reasons": 2,
    "unknown": 0
  },
  "failure_analysis": {
    "main_failure_reasons": [
      "Recruitment issues",
      "Business reasons",
      "Safety issues"
    ],
    "biological_insights": "The failures suggest that the disease biology of glioblastoma is complex and not fully understood. The interventions tested may not be targeting the key pathways involved in disease progression. Additionally, safety is a concern, indicating that the interventions may have off-target effects or other adverse effects that are not tolerable.",
    "common_mechanisms_failed": [
      "EGFR pathway targeting",
      "Immunotherapy (CAR T cells)",
      "Chloroquine"
    ],
    "successful_mechanism_hints": "The lack of efficacy issues suggests that the interventions may have some biological activity, but not sufficient to provide a clinical benefit. It may be worth exploring combination therapies, where multiple pathways are targeted simultaneously. Additionally, further research into the disease biology may identify new targets for intervention.",
    "key_challenges": [
      "Recruitment of suitable patient population",
      "Securing sufficient funding",
      "Safety of interventions",
      "Business decisions affecting trial continuation"
    ]
  },
  "repurposing_candidates": [
    {
      "drug": "temozolomide",
      "total_trials": 5,
      "completed": 4,
      "failed": 1,
      "ongoing": 0,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT00516282",
        "NCT01076530",
        "NCT00099125",
        "NCT00027625",
        "NCT00006025"
      ],
      "repurposing_score": 106.0
    },
    {
      "drug": "Temozolomide",
      "total_trials": 12,
      "completed": 6,
      "failed": 2,
      "ongoing": 1,
      "phases": [
        "PHASE3",
        "PHASE2",
        "PHASE1",
        "PHASE4"
      ],
      "trials": [
        "NCT02414165",
        "NCT01242566",
        "NCT00731731",
        "NCT02209948",
        "NCT00686725",
        "NCT00643825",
        "NCT00643825",
        "NCT00365222",
        "NCT05663125",
        "NCT00525525",
        "NCT04587830",
        "NCT01062425"
      ],
      "repurposing_score": 96.66666666666667
    },
    {
      "drug": "carmustine",
      "total_trials": 2,
      "completed": 2,
      "failed": 0,
      "ongoing": 0,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT00795665",
        "NCT00003348"
      ],
      "repurposing_score": 80.0
    },
    {
      "drug": "irinotecan hydrochloride",
      "total_trials": 2,
      "completed": 2,
      "failed": 0,
      "ongoing": 0,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT00099125",
        "NCT00006025"
      ],
      "repurposing_score": 80.0
    },
    {
      "drug": "Vorinostat",
      "total_trials": 1,
      "completed": 1,
      "failed": 0,
      "ongoing": 0,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT00731731"
      ],
      "repurposing_score": 70.0
    },
    {
      "drug": "terameprocol",
      "total_trials": 1,
      "completed": 1,
      "failed": 0,
      "ongoing": 0,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT00404248"
      ],
      "repurposing_score": 70.0
    },
    {
      "drug": "H-1PV",
      "total_trials": 1,
      "completed": 1,
      "failed": 0,
      "ongoing": 0,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT01301430"
      ],
      "repurposing_score": 70.0
    },
    {
      "drug": "Cyclophosphamide",
      "total_trials": 2,
      "completed": 0,
      "failed": 0,
      "ongoing": 2,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT06640582",
        "NCT01903330"
      ],
      "repurposing_score": 65.0
    },
    {
      "drug": "cediranib maleate",
      "total_trials": 1,
      "completed": 1,
      "failed": 0,
      "ongoing": 0,
      "phases": [
        "PHASE1"
      ],
      "trials": [
        "NCT00458731"
      ],
      "repurposing_score": 55.0
    },
    {
      "drug": "Fludarabine",
      "total_trials": 1,
      "completed": 0,
      "failed": 0,
      "ongoing": 1,
      "phases": [
        "PHASE2",
        "PHASE1"
      ],
      "trials": [
        "NCT06640582"
      ],
      "repurposing_score": 55.0
    }
  ],
  "alternative_targets": [
    {
      "target": "PD-1",
      "inhibitor_count": 18,
      "most_potent_ic50": 3.34,
      "most_advanced_compound": {
        "chembl_id": null,
        "phase": null
      },
      "clinical_trials": {
        "total": 20,
        "recruiting": 6,
        "completed": 7,
        "failed": 2,
        "phases": {
          "PHASE1": 5,
          "PHASE2": 11,
          "PHASE3": 2
        }
      },
      "literature_count": 10,
      "development_score": 0.79,
      "rationale": "PD-1 inhibitors have shown promise in other cancers and could potentially overcome the recruitment and safety issues seen with CAR T cells.",
      "confidence": 0.7
    },
    {
      "target": "VEGF",
      "inhibitor_count": 50,
      "most_potent_ic50": 0.62,
      "most_advanced_compound": {
        "chembl_id": null,
        "phase": null
      },
      "clinical_trials": {
        "total": 20,
        "recruiting": 3,
        "completed": 12,
        "failed": 2,
        "phases": {
          "PHASE1": 2,
          "PHASE2": 8,
          "PHASE3": 2
        }
      },
      "literature_count": 10,
      "development_score": 0.79,
      "rationale": "VEGF inhibitors could potentially address the disease biology by targeting angiogenesis, a key process in glioblastoma progression.",
      "confidence": 0.8
    },
    {
      "target": "IDH1",
      "inhibitor_count": 41,
      "most_potent_ic50": 70.0,
      "most_advanced_compound": {
        "chembl_id": null,
        "phase": null
      },
      "clinical_trials": {
        "total": 20,
        "recruiting": 12,
        "completed": 2,
        "failed": 3,
        "phases": {
          "PHASE1": 10,
          "PHASE2": 7,
          "PHASE3": 1
        }
      },
      "literature_count": 10,
      "development_score": 0.79,
      "rationale": "IDH1 mutations are common in glioblastoma and could be a key driver of disease progression.",
      "confidence": 0.6
    },
    {
      "target": "BRAF",
      "inhibitor_count": 50,
      "most_potent_ic50": 0.3,
      "most_advanced_compound": {
        "chembl_id": "CHEMBL1336",
        "phase": "4.0"
      },
      "clinical_trials": {
        "total": 20,
        "recruiting": 6,
        "completed": 7,
        "failed": 4,
        "phases": {
          "PHASE1": 8,
          "PHASE2": 9,
          "PHASE3": 1
        }
      },
      "literature_count": 10,
      "development_score": 0.78,
      "rationale": "BRAF mutations are less common in glioblastoma, but could be a viable target in a subset of patients.",
      "confidence": 0.5
    },
    {
      "target": "CDK4/6",
      "inhibitor_count": 0,
      "most_potent_ic50": null,
      "most_advanced_compound": {
        "chembl_id": null,
        "phase": null
      },
      "clinical_trials": {
        "total": 20,
        "recruiting": 8,
        "completed": 7,
        "failed": 1,
        "phases": {
          "PHASE1": 4,
          "PHASE2": 7,
          "PHASE3": 7
        }
      },
      "literature_count": 10,
      "development_score": 0.49,
      "rationale": "CDK4/6 inhibitors could potentially address the disease biology by targeting cell cycle regulation, a key process in glioblastoma progression.",
      "confidence": 0.7
    }
  ],
  "failed_trials_sample": [
    {
      "nct_id": "NCT00387894",
      "title": "Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma",
      "status": "TERMINATED",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Adult Brain Tumors"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "erlotinib hydrochloride",
          "description": "Tarceva will be self-administered in an open-label, unblinded manner to all patients enrolled in the study. During the treatment period, patients who are not receiving EIAED (Group A) will receive single-agent Tarceva, 150 mg/day. Patients on EIAED (Group B) will receive single-agent Tarceva, 600 mg/day. Tablets should be taken at the same time each day with 200 mL of water at least 1 hour before or 2 hours after a meal. Patients who are unable to swallow tablets may dissolve the tablets in distilled water for administration. The dose of Tarceva will be escalated after 14 days to 200 mg/day (Group A) or 650 mg/day (Group B) assuming no intolerable grade 2 rash, any grade 3 rash, or grade 2 diarrhea despite loperamide."
        }
      ],
      "start_date": "2007-01",
      "completion_date": "2009-03",
      "enrollment": 6,
      "primary_outcomes": [
        {
          "measure": "Disease Response Measured Objectively by MRI of Brain",
          "description": "Lack of disease progression indicates response to treatment",
          "time_frame": "Every 8 weeks or as indicated"
        }
      ],
      "why_stopped": "Insufficient accrual of population likely to benefit; progression in 6 patients",
      "results_available": true,
      "detailed_results": {
        "resultsSection": {
          "participantFlowModule": {
            "groups": [
              {
                "id": "FG000",
                "title": "Oral Erlotinib Hydrochloride (Tarceva) Daily on Days 1-28",
                "description": "Tarceva self-administered in an open-label, unblinded manner to all patients enrolled. During the treatment period, patients who are not receiving enzyme-inducing antiepileptic drugs (EIAED) will receive single-agent Tarceva, 150 mg/day. Patients on EIAED will receive single-agent Tarceva, 600 mg/day. Tablets should be taken at the same time each day with 200 mL of water at least 1 hour before or 2 hours after a meal. Patients who are unable to swallow tablets may dissolve the tablets in distilled water for administration. The dose of Tarceva will be escalated after 14 days from 150 to 200 mg/day or from 600 to 650 mg/day assuming no intolerable grade 2 rash, any grade 3 rash, or grade 2 diarrhea despite loperamide."
              }
            ],
            "periods": [
              {
                "title": "Overall Study",
                "milestones": [
                  {
                    "type": "STARTED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "6"
                      }
                    ]
                  },
                  {
                    "type": "COMPLETED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "5"
                      }
                    ]
                  },
                  {
                    "type": "NOT COMPLETED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      }
                    ]
                  }
                ],
                "dropWithdraws": [
                  {
                    "type": "Withdrawal by Subject",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "baselineCharacteristicsModule": {
            "groups": [
              {
                "id": "BG000",
                "title": "Oral Erlotinib Hydrochloride (Tarceva) Daily on Days 1-28",
                "description": "erlotinib hydrochloride (Tarceva) self-administered in an open-label, unblinded manner to all patients enrolled in the study."
              }
            ],
            "denoms": [
              {
                "units": "Participants",
                "counts": [
                  {
                    "groupId": "BG000",
                    "value": "6"
                  }
                ]
              }
            ],
            "measures": [
              {
                "title": "Age, Categorical",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "<=18 years",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Between 18 and 65 years",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "6"
                          }
                        ]
                      },
                      {
                        "title": ">=65 years",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Age Continuous",
                "paramType": "MEAN",
                "dispersionType": "FULL_RANGE",
                "unitOfMeasure": "years",
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "44",
                            "lowerLimit": "27",
                            "upperLimit": "60"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Sex: Female, Male",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "Female",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          }
                        ]
                      },
                      {
                        "title": "Male",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "5"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Ethnicity (NIH/OMB)",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "Hispanic or Latino",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Not Hispanic or Latino",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "6"
                          }
                        ]
                      },
                      {
                        "title": "Unknown or Not Reported",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Race (NIH/OMB)",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "American Indian or Alaska Native",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Asian",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          }
                        ]
                      },
                      {
                        "title": "Native Hawaiian or Other Pacific Islander",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Black or African American",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "White",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "5"
                          }
                        ]
                      },
                      {
                        "title": "More than one race",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Unknown or Not Reported",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Region of Enrollment",
                "paramType": "NUMBER",
                "unitOfMeasure": "participants",
                "classes": [
                  {
                    "title": "United States",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "6"
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "outcomeMeasuresModule": {
            "outcomeMeasures": [
              {
                "type": "PRIMARY",
                "title": "Disease Response Measured Objectively by MRI of Brain",
                "description": "Lack of disease progression indicates response to treatment",
                "populationDescription": "5 participants evaluable while receiving study treatment",
                "reportingStatus": "POSTED",
                "paramType": "NUMBER",
                "unitOfMeasure": "participants",
                "timeFrame": "Every 8 weeks or as indicated",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Oral Erlotinib Hydrochloride (Tarceva) Daily on Days 1-28",
                    "description": "erlotinib hydrochloride (Tarceva) self-administered in an open-label, unblinded manner to all patients enrolled in the study."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "5"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Disease progression prior to 8 weeks",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Disease responsive at 8 Weeks",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Disease responsive at 16 Weeks",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Duration of Progress-free Survival (PFS)",
                "description": "Patients with stable or responding disease will continue treatment until tumor progression is determined",
                "reportingStatus": "POSTED",
                "paramType": "NUMBER",
                "unitOfMeasure": "participants",
                "timeFrame": "Until first observation of progressive disease, non-reversible neurologic progression or permanently increased steroid requirement (stable disease only), death due to any cause (up to 16 weeks)",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Oral Erlotinib Hydrochloride (Tarceva) Daily on Days 1-28",
                    "description": "erlotinib hydrochloride (Tarceva) self-administered in an open-label, unblinded manner to all patients enrolled in the study."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "5"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "2 weeks PFS",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "3 weeks PFS",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "6 weeks PFS",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "12 weeks PFS",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "30 days after the last study treatment, thereafter for survival",
            "description": "Only AEs Grade 3 or higher were required to be collected as AEs, per protocol",
            "eventGroups": [
              {
                "id": "EG000",
                "title": "Oral Erlotinib Hydrochloride (Tarceva) Daily on Days 1-28",
                "description": "erlotinib hydrochloride (Tarceva) self-administered in an open-label, unblinded manner to all patients enrolled in the study.",
                "seriousNumAffected": 6,
                "seriousNumAtRisk": 6,
                "otherNumAffected": 0,
                "otherNumAtRisk": 6
              }
            ],
            "seriousEvents": [
              {
                "term": "Disease progression",
                "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "notes": "All participants died due to disease progression",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 6,
                    "numAffected": 6,
                    "numAtRisk": 6
                  }
                ]
              },
              {
                "term": "Neuropathy",
                "organSystem": "Nervous system disorders",
                "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                "notes": "Grade 3, not related to treatment",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 6
                  }
                ]
              },
              {
                "term": "Wound complication",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                "notes": "Grade 3, not related to treatment",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 6
                  }
                ]
              },
              {
                "term": "Seizure",
                "organSystem": "General disorders",
                "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                "notes": "Grade 3, not related to treatment",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 6
                  }
                ]
              },
              {
                "term": "Confusion",
                "organSystem": "General disorders",
                "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                "notes": "Grade 3, not related to treatment",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 6
                  }
                ]
              }
            ]
          },
          "moreInfoModule": {
            "limitationsAndCaveats": {
              "description": "The study was terminated early for 2 reasons: 1. ongoing literature at the time confirming that the selection process was not likely to enrich for a patient population expected to benefit, and 2. Rapid disease progression in the first 6 patients."
            },
            "certainAgreement": {
              "piSponsorEmployee": true,
              "restrictiveAgreement": false
            },
            "pointOfContact": {
              "title": "Michael Prados, MD",
              "organization": "University of California San Francisco",
              "email": "PradosM@neurosurg.ucsf.edu",
              "phone": "415-353-7500"
            }
          }
        }
      }
    },
    {
      "nct_id": "NCT02521090",
      "title": "EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma",
      "status": "WITHDRAWN",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Adult Brain Glioblastoma",
        "Adult Gliosarcoma",
        "Recurrent Brain Neoplasm"
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "EGFRBi-Armed Autologous T Cells",
          "description": "Given IT and IV"
        },
        {
          "type": "OTHER",
          "name": "Laboratory Biomarker Analysis",
          "description": "Correlative studies"
        }
      ],
      "start_date": "2015-08",
      "completion_date": null,
      "enrollment": 0,
      "primary_outcomes": [
        {
          "measure": "Incidence of toxicity according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0 (Phase I)",
          "description": "",
          "time_frame": "Up to 7 days after the last infusion"
        },
        {
          "measure": "Overall survival (OS) (Phase II)",
          "description": "The median OS will be estimated with 95% confidence interval. Kaplan-Meier estimate of OS will be plotted. For quantitative measurements in immune evaluations, will calculate their means, standard deviations, medians, and examine the distributions of these data to ascertain whether normal theory methods are appropriate. Paired t-test or Wilcoxon signed-ranks test will be used for comparative analyses between each post-IMT time point versus pre-IMT.",
          "time_frame": "From study enrollment to death due to any cause, assessed up to 2 years"
        }
      ],
      "why_stopped": "Due to lack of funding and a primary co-investigator of the trial leaving the institution.",
      "results_available": false
    },
    {
      "nct_id": "NCT03419403",
      "title": "UNITE Study: Understanding New Interventions With GBM ThErapy",
      "status": "TERMINATED",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Glioblastoma Multiforme"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Steroid eye drops",
          "description": "Solution, eye drop"
        },
        {
          "type": "DRUG",
          "name": "Vasoconstrictor eye drops",
          "description": "Solution, eye drop"
        },
        {
          "type": "OTHER",
          "name": "Cold compress",
          "description": "Cold compress"
        },
        {
          "type": "DRUG",
          "name": "Ophthalmic steroid ointment",
          "description": "Ointment"
        },
        {
          "type": "DRUG",
          "name": "Depatuxizumab mafodotin",
          "description": "During the Chemoradiation Phase, participants were to receive depatuxizumab mafodotin at 2.0 mg/kg IV infusion over 30 - 40 minutes once every 2 weeks (Day 1 of Weeks 1, 3, and 5 of the 6-week regimen). During the Adjuvant Therapy Phase, participants were to receive depatuxizumab mafodotin at 1.25 mg/kg on Day 1 (\u00b1 2 days) and Day 15 (\u00b1 2 days) of each 28-day cycle as a 30 - 40 minute infusion for 12 cycles."
        },
        {
          "type": "DRUG",
          "name": "Temozolomide",
          "description": "Temozolomide was to be administered according to the local standard of care. Duration of treatment was to be 6 - 12 cycles in the adjuvant phase and at the discretion of the investigator as supported by local standard of care."
        },
        {
          "type": "RADIATION",
          "name": "Radiation",
          "description": "Radiation therapy treatment planning and administration was to be performed as per local institutional guidelines."
        }
      ],
      "start_date": "2018-07-30",
      "completion_date": "2020-03-03",
      "enrollment": 40,
      "primary_outcomes": [
        {
          "measure": "Percentage of Participants Who Required a Change in Ocular Side Effect (OSE) Management",
          "description": "Inadequate control of ocular side effects (OSE) was defined as either a \u2265 3-line decline from baseline (\u2265 +0.3 on LogMAR scale) in visual acuity (with baseline correction determined at the screening ophthalmology visit)) or \u2265 Grade 3 OSE severity on the Corneal Epithelial Adverse Event (CEAE) scale.",
          "time_frame": "Within 8 weeks after the initial dose of depatuxizumab mafodotin"
        }
      ],
      "why_stopped": "The study was terminated because clinical development of depatuxizumab mafodotin in glioblastoma was stopped due to lack of survival benefit.",
      "results_available": true,
      "detailed_results": {
        "resultsSection": {
          "participantFlowModule": {
            "preAssignmentDetails": "All randomized participants",
            "groups": [
              {
                "id": "FG000",
                "title": "Standard Steroids",
                "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
              },
              {
                "id": "FG001",
                "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
              },
              {
                "id": "FG002",
                "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
              },
              {
                "id": "FG003",
                "title": "Untreated Participants",
                "description": "Participants who were randomized to the study but received no doses of depatuxizumab mafodotin or prophylactic eye treatments"
              }
            ],
            "periods": [
              {
                "title": "Overall Study",
                "milestones": [
                  {
                    "type": "STARTED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "14"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "12"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "12"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "2"
                      }
                    ]
                  },
                  {
                    "type": "COMPLETED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "0"
                      }
                    ]
                  },
                  {
                    "type": "NOT COMPLETED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "12"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "9"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "12"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "2"
                      }
                    ]
                  }
                ],
                "dropWithdraws": [
                  {
                    "type": "Withdrawal by Subject",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "5"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "5"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "1"
                      }
                    ]
                  },
                  {
                    "type": "Progressive disease (per protocol)",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "0"
                      }
                    ]
                  },
                  {
                    "type": "Other, not specified",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "6"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "5"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "1"
                      }
                    ]
                  },
                  {
                    "type": "Left study due to COVID-19 restrictions",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "0"
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "baselineCharacteristicsModule": {
            "populationDescription": "Safety population: All randomized participants who received at least 1 dose of depatuxizumab mafodotin",
            "groups": [
              {
                "id": "BG000",
                "title": "Standard Steroids",
                "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
              },
              {
                "id": "BG001",
                "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
              },
              {
                "id": "BG002",
                "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
              },
              {
                "id": "BG003",
                "title": "Total",
                "description": "Total of all reporting groups"
              }
            ],
            "denoms": [
              {
                "units": "Participants",
                "counts": [
                  {
                    "groupId": "BG000",
                    "value": "14"
                  },
                  {
                    "groupId": "BG001",
                    "value": "12"
                  },
                  {
                    "groupId": "BG002",
                    "value": "12"
                  },
                  {
                    "groupId": "BG003",
                    "value": "38"
                  }
                ]
              }
            ],
            "measures": [
              {
                "title": "Age, Continuous",
                "paramType": "MEAN",
                "dispersionType": "STANDARD_DEVIATION",
                "unitOfMeasure": "years",
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "47.6",
                            "spread": "9.85"
                          },
                          {
                            "groupId": "BG001",
                            "value": "55.2",
                            "spread": "10.53"
                          },
                          {
                            "groupId": "BG002",
                            "value": "57.3",
                            "spread": "8.69"
                          },
                          {
                            "groupId": "BG003",
                            "value": "53.1",
                            "spread": "10.39"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Sex: Female, Male",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "calculatePct": false,
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "Female",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "3"
                          },
                          {
                            "groupId": "BG001",
                            "value": "4"
                          },
                          {
                            "groupId": "BG002",
                            "value": "1"
                          },
                          {
                            "groupId": "BG003",
                            "value": "8"
                          }
                        ]
                      },
                      {
                        "title": "Male",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "11"
                          },
                          {
                            "groupId": "BG001",
                            "value": "8"
                          },
                          {
                            "groupId": "BG002",
                            "value": "11"
                          },
                          {
                            "groupId": "BG003",
                            "value": "30"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Race/Ethnicity, Customized",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "calculatePct": false,
                "classes": [
                  {
                    "title": "White",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "12"
                          },
                          {
                            "groupId": "BG001",
                            "value": "12"
                          },
                          {
                            "groupId": "BG002",
                            "value": "12"
                          },
                          {
                            "groupId": "BG003",
                            "value": "36"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Black or African American",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Asian",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "outcomeMeasuresModule": {
            "outcomeMeasures": [
              {
                "type": "PRIMARY",
                "title": "Percentage of Participants Who Required a Change in Ocular Side Effect (OSE) Management",
                "description": "Inadequate control of ocular side effects (OSE) was defined as either a \u2265 3-line decline from baseline (\u2265 +0.3 on LogMAR scale) in visual acuity (with baseline correction determined at the screening ophthalmology visit)) or \u2265 Grade 3 OSE severity on the Corneal Epithelial Adverse Event (CEAE) scale.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had at least 1 post-baseline assessment within 8 weeks after the initial dose for either LogMAR or CEAE",
                "reportingStatus": "POSTED",
                "paramType": "NUMBER",
                "unitOfMeasure": "percentage of participants",
                "timeFrame": "Within 8 weeks after the initial dose of depatuxizumab mafodotin",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "14"
                      },
                      {
                        "groupId": "OG001",
                        "value": "12"
                      },
                      {
                        "groupId": "OG002",
                        "value": "12"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Bilateral vision",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "50.0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "27.3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "41.7"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Vision in worst eye",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "64.3"
                          },
                          {
                            "groupId": "OG001",
                            "value": "72.7"
                          },
                          {
                            "groupId": "OG002",
                            "value": "50.0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Maximum Change From Baseline on the Logarithm of the Minimum Angle of Resolution (LogMAR) Scale",
                "description": "The LogMAR scale measures visual acuity on a continuous scale, with a LogMAR value of 0 equivalent to 20/20 visual acuity. Normal vision is considered to be from -0.2 - 0.1; higher values indicate visual impairment. The baseline observation is defined as the last non-missing measurement collected prior to the first dose of depatuxizumab mafodotin.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data.",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Standard Deviation",
                "unitOfMeasure": "units on a scale",
                "timeFrame": "Within 8 weeks after the initial dose of depatuxizumab mafodotin",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "12"
                      },
                      {
                        "groupId": "OG001",
                        "value": "10"
                      },
                      {
                        "groupId": "OG002",
                        "value": "9"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Bilateral vision",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.353",
                            "spread": "0.1888"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.402",
                            "spread": "0.1985"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.272",
                            "spread": "0.3888"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Vision in worst eye",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.482",
                            "spread": "0.2028"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.528",
                            "spread": "0.3073"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.430",
                            "spread": "0.5120"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Time to Bandage Contact Lens (BCL) Intervention",
                "description": "The time to initiation of bandage contact lenses for those participants who required intervention due to inadequate control of ocular side effects (OSE) was calculated.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "MEDIAN",
                "dispersionType": "95% Confidence Interval",
                "unitOfMeasure": "months",
                "timeFrame": "Up to 9 months after the first dose of depatuxizumab mafodotin",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "14"
                      },
                      {
                        "groupId": "OG001",
                        "value": "12"
                      },
                      {
                        "groupId": "OG002",
                        "value": "12"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "NA",
                            "lowerLimit": "1.1",
                            "upperLimit": "NA",
                            "comment": "Not calculable due to insufficient number of participants with events"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3.6",
                            "lowerLimit": "1.1",
                            "upperLimit": "NA",
                            "comment": "Not calculable due to insufficient number of participants with events"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2.1",
                            "lowerLimit": "1.1",
                            "upperLimit": "NA",
                            "comment": "Not calculable due to insufficient number of participants with events"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Number of Participants With Depatuxizumab Mafodotin Dose Modifications Due to Ocular Side Effects (OSE)",
                "description": "Dose modifications included depatuxizumab mafodotin withdrawal, interruption, and reductions in dose initiated due to OSEs.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "calculatePct": false,
                "timeFrame": "From the first dose of study drug until 49 days after last depatuxizumab mafodotin administration, up to 47 weeks",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "14"
                      },
                      {
                        "groupId": "OG001",
                        "value": "12"
                      },
                      {
                        "groupId": "OG002",
                        "value": "12"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Cumulative Dose of Depatuxizumab Mafodotin Received During Chemoradiation and During Adjuvant Treatment",
                "description": "The cumulative dose of depatuxizumab mafodotin administered was tabulated.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Standard Deviation",
                "unitOfMeasure": "mg/kg",
                "timeFrame": "Up to 9 months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "14"
                      },
                      {
                        "groupId": "OG001",
                        "value": "12"
                      },
                      {
                        "groupId": "OG002",
                        "value": "12"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "8.5",
                            "spread": "5.86"
                          },
                          {
                            "groupId": "OG001",
                            "value": "10.5",
                            "spread": "7.35"
                          },
                          {
                            "groupId": "OG002",
                            "value": "7.0",
                            "spread": "3.67"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Treatment-Emergent Corneal Epithelial Adverse Event (CEAE) Grade at Each Visit",
                "description": "The corneal epithelial adverse event (CEAE) rating scale is designed to record symptoms associated with corneal epitheliopathy caused by antibody-drug conjugates and to grade the severity of findings. The overall CEAE grade is measured on a scale of 0 to 5, with higher values being more severe, reflecting the impact of corneal abnormalities on visual activities of daily living (ADLs). Additional detailed information is collected for specific domains that are commonly affected, with the following ranges (each in order of increasing severity): ocular discomfort (0 - 4), photophobia (0 - 3), and reading (1 - 3).",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "calculatePct": false,
                "timeFrame": "Up to 47 weeks",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "14"
                      },
                      {
                        "groupId": "OG001",
                        "value": "12"
                      },
                      {
                        "groupId": "OG002",
                        "value": "12"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Week 1: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "10"
                          },
                          {
                            "groupId": "OG001",
                            "value": "8"
                          },
                          {
                            "groupId": "OG002",
                            "value": "5"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 1: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 3: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          },
                          {
                            "groupId": "OG001",
                            "value": "5"
                          },
                          {
                            "groupId": "OG002",
                            "value": "7"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 3: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "10"
                          },
                          {
                            "groupId": "OG001",
                            "value": "6"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 3: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 5: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 5: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "7"
                          },
                          {
                            "groupId": "OG001",
                            "value": "5"
                          },
                          {
                            "groupId": "OG002",
                            "value": "6"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 5: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 5: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 7: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 7: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "3"
                          },
                          {
                            "groupId": "OG001",
                            "value": "4"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 7: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          },
                          {
                            "groupId": "OG001",
                            "value": "6"
                          },
                          {
                            "groupId": "OG002",
                            "value": "5"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 7: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 9: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 9: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 9: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "3"
                          },
                          {
                            "groupId": "OG001",
                            "value": "5"
                          },
                          {
                            "groupId": "OG002",
                            "value": "4"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 9: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 4",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 13: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 1: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 1: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 1: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "3"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 1: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 17: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 17: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 17: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 21: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 21: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 25: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 25: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 29: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 29: Grade 4",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Change From Baseline In Logarithm of the Minimum Angle of Resolution (LogMAR) Scale After Bandage Contact Lens (BCL) Intervention",
                "description": "The change on the LogMAR Scale from last assessment prior to BCL intervention to 2 weeks after BCL intervention was calculated. The LogMAR scale measures visual acuity on a continuous scale, with a LogMAR value of 0 equivalent to 20/20 visual acuity. Normal vision is considered to be from -0.2 - 0.1; higher values indicate visual impairment.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Standard Deviation",
                "unitOfMeasure": "units on a scale",
                "timeFrame": "From the last assessment prior to BCL intervention to 2 weeks after BCL intervention",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "4"
                      },
                      {
                        "groupId": "OG001",
                        "value": "2"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Within 8 weeks of first dose: Bilateral vision",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.325",
                            "spread": "0.1248"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.13",
                            "spread": "0.099"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.54",
                            "spread": "0.1442"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Within 8 weeks of first dose: Vision in worst eye",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "4"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.435",
                            "spread": "0.0574"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.52",
                            "spread": "0.3111"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.867",
                            "spread": "0.2914"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Within 8 weeks of first adjuvant dose: Bilateral vision",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "-0.1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.41",
                            "spread": "0.2404"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Within 8 weeks of first adjuvant dose: Vision in worst eye",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "-0.1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.33",
                            "spread": "0.0141"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Percentage of Participants That Recovered to <3-line Decline From Baseline (\u2264 +0.3 LogMAR) in Visual Acuity After Bandage Contact Lens (BCL) Intervention",
                "description": "Recovery was defined as return to \\<3-line decline from baseline (\u2264 +0.3 LogMAR) in visual acuity after BCL intervention.",
                "populationDescription": "Data were not collected for this outcome (due to early termination of the study).",
                "reportingStatus": "POSTED",
                "timeFrame": "From the last assessment prior to BCL intervention to the end of BCL intervention",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "0"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Number of Participants With Depatuxizumab Mafodotin Dose Modifications to Ocular Side Effects After Bandage Contact Lens (BCL) Intervention",
                "description": "Dose modifications included depatuxizumab mafodotin withdrawal, interruption, and reductions in dose initiated due to OSEs after BCL intervention.",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "NUMBER",
                "unitOfMeasure": "participants",
                "timeFrame": "From the last assessment prior to BCL intervention to the end of BCL intervention, up to 38 weeks",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "14"
                      },
                      {
                        "groupId": "OG001",
                        "value": "12"
                      },
                      {
                        "groupId": "OG002",
                        "value": "12"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Time to Restart Depatuxizumab Mafodotin if Interrupted Due to Ocular Side Effects After Bandage Contact Lens (BCL) Intervention",
                "description": "The time to restart depatuxizumab mafodotin treatment if it was interrupted due to ocular side effects after BCL Intervention was tabulated.",
                "populationDescription": "Data were not collected for this outcome (due to early termination of the study).",
                "reportingStatus": "POSTED",
                "timeFrame": "From the last assessment prior to BCL intervention to the end of BCL intervention",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "0"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Treatment Emergent Corneal Epithelial Adverse Event (CEAE) Grade at Each Visit After Bandage Contact Lens (BCL) Intervention",
                "description": "The corneal epithelial adverse event (CEAE) rating scale is designed to record symptoms associated with corneal epitheliopathy caused by antibody-drug conjugates and to grade the severity of findings. The overall CEAE grade is measured on a scale of 0 to 5, with higher values being more severe, reflecting the impact of corneal abnormalities on visual activities of daily living (ADLs). Additional detailed information is collected for specific domains that are commonly affected, with the following ranges (each in order of increasing severity): ocular discomfort (0 - 4), photophobia (0 - 3), and reading (1 - 3).",
                "populationDescription": "Safety population: all randomized participants who received at least 1 dose of depatuxizumab mafodotin and had available data",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "calculatePct": false,
                "timeFrame": "From the last assessment prior to BCL intervention to the end of BCL intervention, up to 38 weeks",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "7"
                      },
                      {
                        "groupId": "OG001",
                        "value": "4"
                      },
                      {
                        "groupId": "OG002",
                        "value": "4"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Week 5: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 7: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 9: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 11: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Week 13: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 1: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 1: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 5: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 9: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 0",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 13: Grade 3",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 17: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 17: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 21: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 25: Grade 1",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 25: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Adj Week 29: Grade 2",
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Time to Ocular Side Effect (OSE) Symptom Resolution After Drug Discontinuation (Reversibility)",
                "description": "The time from discontinuation of depatuxizumab mafodotin to OSE symptom resolution (reversibility) was to be recorded.",
                "populationDescription": "Data were not collected for this outcome (due to early termination of the study).",
                "reportingStatus": "POSTED",
                "timeFrame": "From the first dose of study drug until 49 days after last depatuxizumab mafodotin administration, up to 47 weeks",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "0"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Time to Re-initiation of Depatuxizumab Mafodotin After Dose Interruption",
                "description": "The time from dose interruption until re-initiation or permanent discontinuation of depatuxizumab mafodotin was to be recorded.",
                "populationDescription": "Data were not collected for this outcome (due to early termination of the study).",
                "reportingStatus": "POSTED",
                "timeFrame": "Up to 9 months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "Standard Steroids",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days"
                  },
                  {
                    "id": "OG001",
                    "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable)."
                  },
                  {
                    "id": "OG002",
                    "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                    "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable)."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "0"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Treatment-emergent adverse events (TEAEs) and serious adverse events (TESAEs) were collected from the first dose of study drug until 49 days after last depatuxizumab mafodotin administration, up to 47 weeks. In addition, serious adverse events and protocol-related nonserious adverse events were collected from the time the participant signed the study-specific informed consent.",
            "description": "TEAEs and SAEs are defined as any AE or SAE with onset or worsening reported by a participant from the time that the first dose of depatuxizumab mafodotin is administered until 49 days have elapsed following discontinuation of study drug. TEAEs were collected whether elicited or spontaneously reported by the participant.",
            "eventGroups": [
              {
                "id": "EG000",
                "title": "Standard Steroids",
                "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days",
                "deathsNumAffected": 1,
                "deathsNumAtRisk": 14,
                "seriousNumAffected": 6,
                "seriousNumAtRisk": 14,
                "otherNumAffected": 14,
                "otherNumAtRisk": 14
              },
              {
                "id": "EG001",
                "title": "Standard Steroids + Vasoconstrictor + Cold Compress",
                "description": "Steroid eye drops: 1 drop each eye, 3 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. The cold compress was to be applied in increments no longer than 30 min (could be shorter if the participant was uncomfortable).",
                "deathsNumAffected": 1,
                "deathsNumAtRisk": 12,
                "seriousNumAffected": 4,
                "seriousNumAtRisk": 12,
                "otherNumAffected": 12,
                "otherNumAtRisk": 12
              },
              {
                "id": "EG002",
                "title": "Enhanced Steroids + Vasoconstrictor + Cold Compress",
                "description": "Enhanced steroid eye drops: 1 drop each eye, 6 times/day, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Ophthalmic Steroid Ointment; applied to each eye once daily before sleep, starting 2 days prior to depatuxizumab mafodotin infusion and continuing until 4 days after infusion, for a total of 7 days; Vasoconstrictor Eye Drops: 1 drop each eye 4 - 6 times on day of infusion in total (5 - 10 minutes before infusion; at end of infusion; and 2 - 4 times during the remainder of the infusion day). Continuing 4 - 6 times/day on Day 1 and Day 2 after each depatuxizumab mafodotin infusion; Cold Compress: Starting 5 minutes prior to start of infusion and continuing for 30 minutes past end of infusion, and then use at least 2 hours total/day on Days 1 - 3 with each depatuxizumab mafodotin infusion. Cold compress was to be applied in increments no longer than 30 min (could be shorter if the patient is uncomfortable).",
                "deathsNumAffected": 1,
                "deathsNumAtRisk": 12,
                "seriousNumAffected": 4,
                "seriousNumAtRisk": 12,
                "otherNumAffected": 12,
                "otherNumAtRisk": 12
              }
            ],
            "seriousEvents": [
              {
                "term": "FEBRILE NEUTROPENIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "THROMBOCYTOPENIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ULCERATIVE KERATITIS",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "VOMITING",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PYREXIA",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CELLULITIS",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "EYE INFECTION",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "LOWER RESPIRATORY TRACT INFECTION",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PNEUMONIA",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ALANINE AMINOTRANSFERASE INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MALIGNANT NEOPLASM PROGRESSION",
                "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "TUMOUR PSEUDOPROGRESSION",
                "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HEADACHE",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HEMIPARESIS",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "SEIZURE",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "STATUS EPILEPTICUS",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PULMONARY EMBOLISM",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DEEP VEIN THROMBOSIS",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HAEMATOMA",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              }
            ],
            "otherEvents": [
              {
                "term": "ANAEMIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "LEUKOPENIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "LYMPHOPENIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NEUTROPENIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "THROMBOCYTOPENIA",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 4,
                    "numAffected": 3,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 7,
                    "numAffected": 5,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 7,
                    "numAffected": 3,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CARDIOMEGALY",
                "organSystem": "Cardiac disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "TACHYCARDIA",
                "organSystem": "Cardiac disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "EAR PAIN",
                "organSystem": "Ear and labyrinth disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HYPOACUSIS",
                "organSystem": "Ear and labyrinth disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ACQUIRED EPIBLEPHARON",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CONJUNCTIVITIS ALLERGIC",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DIPLOPIA",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DRY EYE",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "EYELID PTOSIS",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "FOREIGN BODY SENSATION IN EYES",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "VISION BLURRED",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ABDOMINAL DISTENSION",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ANAL INCONTINENCE",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CONSTIPATION",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 5,
                    "numAffected": 5,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 4,
                    "numAffected": 4,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DIARRHOEA",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DRY MOUTH",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DUODENAL ULCER",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DYSPHAGIA",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "GASTRITIS EROSIVE",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HAEMORRHOIDAL HAEMORRHAGE",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HAEMORRHOIDS",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MOUTH ULCERATION",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NAUSEA",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 7,
                    "numAffected": 6,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 7,
                    "numAffected": 6,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 3,
                    "numAffected": 3,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "STOMATITIS",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "VOMITING",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 5,
                    "numAffected": 5,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ASTHENIA",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CHEST PAIN",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "FATIGUE",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 10,
                    "numAffected": 6,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 10,
                    "numAffected": 9,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 8,
                    "numAffected": 7,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "INFLUENZA LIKE ILLNESS",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "OEDEMA PERIPHERAL",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PYREXIA",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DRUG-INDUCED LIVER INJURY",
                "organSystem": "Hepatobiliary disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 3,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HYPERSENSITIVITY",
                "organSystem": "Immune system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BALANITIS CANDIDA",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NASOPHARYNGITIS",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ORAL CANDIDIASIS",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ORAL HERPES",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "SINUSITIS",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "UPPER RESPIRATORY TRACT INFECTION",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "URINARY TRACT INFECTION",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ARTHROPOD BITE",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CORNEAL ABRASION",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "FALL",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 3,
                    "numAffected": 2,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "INCISION SITE PAIN",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "INFUSION RELATED REACTION",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "RADIATION NECROSIS",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "RADIATION SKIN INJURY",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "SKIN ABRASION",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ALANINE AMINOTRANSFERASE INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 7,
                    "numAffected": 5,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 4,
                    "numAffected": 3,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ASPARTATE AMINOTRANSFERASE INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 4,
                    "numAffected": 4,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 3,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BLOOD BILIRUBIN ABNORMAL",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BLOOD CALCIUM INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BLOOD CREATININE INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BLOOD PHOSPHORUS DECREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CARDIAC MURMUR",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "GAMMA-GLUTAMYLTRANSFERASE INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "INTRAOCULAR PRESSURE INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "LYMPHOCYTE COUNT DECREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 7,
                    "numAffected": 3,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NEUTROPHIL COUNT DECREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NEUTROPHIL COUNT INCREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "WEIGHT DECREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "WHITE BLOOD CELL COUNT DECREASED",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DECREASED APPETITE",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 4,
                    "numAffected": 3,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 5,
                    "numAffected": 3,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 3,
                    "numAffected": 3,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DEHYDRATION",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HYPERGLYCAEMIA",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HYPOKALAEMIA",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HYPONATRAEMIA",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MALNUTRITION",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ARTHRALGIA",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BACK PAIN",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MUSCULAR WEAKNESS",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 5,
                    "numAffected": 2,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MUSCULOSKELETAL CHEST PAIN",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NECK PAIN",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "APHASIA",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "APRAXIA",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BALANCE DISORDER",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "BRAIN OEDEMA",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CEREBRAL HAEMORRHAGE",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DIZZINESS",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DYSGEUSIA",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 3,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HEADACHE",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 5,
                    "numAffected": 5,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 3,
                    "numAffected": 3,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 5,
                    "numAffected": 4,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HEMIPARESIS",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MEMORY IMPAIRMENT",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "SEIZURE",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 3,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "SYNCOPE",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "TREMOR",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "VASOGENIC CEREBRAL OEDEMA",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "AGITATION",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ANXIETY",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 3,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "CONFUSIONAL STATE",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DEPRESSION",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "INSOMNIA",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "NOCTURIA",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "URINARY INCONTINENCE",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "MENSTRUATION IRREGULAR",
                "organSystem": "Reproductive system and breast disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PROSTATIC OBSTRUCTION",
                "organSystem": "Reproductive system and breast disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "COUGH",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 4,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DYSPNOEA EXERTIONAL",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "EPISTAXIS",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "OROPHARYNGEAL PAIN",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PLEURITIC PAIN",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PULMONARY OEDEMA",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "RHINITIS ALLERGIC",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ALOPECIA",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 7,
                    "numAffected": 5,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DERMATITIS",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DERMATITIS ACNEIFORM",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DRY SKIN",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "ERYTHEMA",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 2,
                    "numAffected": 2,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "PETECHIAE",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "RASH",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 4,
                    "numAffected": 3,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "RASH MACULO-PAPULAR",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "RASH PRURITIC",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "SCAR PAIN",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "DEEP VEIN THROMBOSIS",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              },
              {
                "term": "HYPOTENSION",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 22.1",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numEvents": 0,
                    "numAffected": 0,
                    "numAtRisk": 14
                  },
                  {
                    "groupId": "EG001",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  },
                  {
                    "groupId": "EG002",
                    "numEvents": 1,
                    "numAffected": 1,
                    "numAtRisk": 12
                  }
                ]
              }
            ]
          },
          "moreInfoModule": {
            "certainAgreement": {
              "piSponsorEmployee": false,
              "restrictionType": "OTHER",
              "restrictiveAgreement": true,
              "otherDetails": "AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection."
            },
            "pointOfContact": {
              "title": "Global Medical Services",
              "organization": "AbbVie",
              "email": "abbvieclinicaltrials@abbvie.com",
              "phone": "800-633-9110"
            }
          }
        }
      }
    },
    {
      "nct_id": "NCT02365662",
      "title": "A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor",
      "status": "TERMINATED",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Head and Neck Squamous Cell Carcinoma",
        "Non-small Cell Lung Cancer",
        "Triple Negative Breast Cancer",
        "Colorectal Carcinoma",
        "Glioblastoma Multiforme"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "ABBV-221",
          "description": "ABBV-221 will be given either every 3 weeks or 2 weeks on, 1 week off or weekly dosing by intravenous infusion approximately over 30 minutes to 3 hours. This is a dose escalation study, therefore the dose of ABBV-221 will change throughout the study."
        }
      ],
      "start_date": "2015-01-09",
      "completion_date": "2018-03-15",
      "enrollment": 46,
      "primary_outcomes": [
        {
          "measure": "Number of participants with adverse events",
          "description": "Adverse event monitoring will be performed during the study",
          "time_frame": "Measured for approximately 4 years"
        },
        {
          "measure": "Maximum Plasma Concentration (Cmax) of ABBV-221",
          "description": "The maximum plasma concentration (Cmax; measured in ng/mL) is the highest concentration that a drug achieves in the plasma after administration in a dosing interval.",
          "time_frame": "Blood samples will be collected before infusion (0 hour, pre-dose) on Cycle 1 Day 1 (C1D1), C1D2, C1D3, C1D5, C1D8, C1D15, C2D1, C3D1, C3D2, C3D3, C3D5, C3D8, C3D15, every 2 cycles starting with Cycle 5, and at the final visit (approximately 2 years)."
        },
        {
          "measure": "Area Under the Plasma Concentration-time Curve from 0 to the Time of the Last Measurable Concentration (AUCt) of ABBV-221",
          "description": "The area under the plasma concentration-time curve (AUC; measured in ng\\*hr/mL) is a method of measurement of the total exposure of a drug in blood plasma.",
          "time_frame": "Blood samples will be collected before infusion (0 hour, pre-dose) on Cycle 1 Day 1 (C1D1), C1D2, C1D3, C1D5, C1D8, C1D15, C2D1, C3D1, C3D2, C3D3, C3D5, C3D8, C3D15, every 2 cycles starting with Cycle 5, and at the final visit (approximately 2 years)."
        },
        {
          "measure": "Maximum tolerated dose of ABBV-221",
          "description": "The highest dose level at which less than 2 of 6 participants or less than 33% of (if cohort is expanded beyond 6) participants experience a dose limiting toxicity.",
          "time_frame": "Up to 2 years from first dose of study drug."
        },
        {
          "measure": "Area Under the Plasma Concentration-time Curve of ABBV-221",
          "description": "The area under the plasma concentration-time curve (AUC; measured in ng\\*hr/mL) is a method of measurement of the total exposure of a drug in blood plasma.",
          "time_frame": "Blood samples will be collected before infusion (0 hour, pre-dose) on Cycle 1 Day 1 (C1D1), C1D2, C1D3, C1D5, C1D8, C1D15, C2D1, C3D1, C3D2, C3D3, C3D5, C3D8, C3D15, every 2 cycles starting with Cycle 5, and at the final visit (approximately 2 years)."
        },
        {
          "measure": "Recommended Phase 2 dose of ABBV-221",
          "description": "If a maximum tolerated dose (MTD) is reached, the recommended Phase 2 dose (RPTD) of ABBV-221 will not be a dose higher than the defined MTD, and will be selected based on the type(s) and occurrence(s) of dose limiting toxicities which occur in addition to the MTD. If a MTD is not reached, then the RPTD will be defined based on the safety and pharmacokinetic data.",
          "time_frame": "1 day of study drug administration within the 21-day cycle at the designated cohort dose"
        }
      ],
      "why_stopped": "Safety",
      "results_available": false
    },
    {
      "nct_id": "NCT03296696",
      "title": "Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma",
      "status": "TERMINATED",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Glioblastoma or Malignant Glioma"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "AMG 596",
          "description": "Drug"
        },
        {
          "type": "DRUG",
          "name": "AMG 404",
          "description": "Drug"
        }
      ],
      "start_date": "2018-04-18",
      "completion_date": "2021-08-28",
      "enrollment": 30,
      "primary_outcomes": [
        {
          "measure": "Number of Participants With Dose-Limiting Toxicities (DLTs)",
          "description": "A DLT was any of the following occurring and regarded by the investigator as related to AMG 596. Hematological DLTs: absolute neutrophil count (ANC) \\<0.5\u00d710\\^9/L for \u22657 days, febrile neutropenia with ANC\\<0.5\u00d710\\^9/L and fever \u226538.5\u00b0C, platelets\\<50\u00d710\\^9/L\\>7 days or clinically significant bleeding. Non-hematological DLTs: any grade 4 non-hematological toxicity, any grade \u22653 non-hematological toxicity if nausea and vomiting, grade 3 non-hematologic toxicity lasting \\>3 days despite treatment, grade 3 fatigue wasn't classified as DLT, grade 3 acute kidney injury, grade 3 seizure, ataxia, encephalopathy, other grade 3 neurologic-related adverse events lasting \\>3 days despite treatment, neurologic-related adverse event leading to treatment interruption needing\\>1 week to resolve to grade\u22641, any grade 3 endocrinopathy that can't be controlled by hormonal replacement. Toxicity grading was graded using the Common Terminology Criteria for Adverse Events (CTCAE v4.0)",
          "time_frame": "Up to 28 days"
        },
        {
          "measure": "Number of Participants With Treatment Emergent Adverse Events (TEAEs)",
          "description": "An adverse event (AE) was defined as any untoward medical occurrence in a clinical trial participant. A TEAE was any AE that begun or worsened after the initial dose of investigational product. Any clinically significant changes in vital signs, physical examinations, and clinical laboratory tests that begun or worsened after the initial dose of investigational product were recorded as TEAEs.",
          "time_frame": "First dose of study drug until 37 days after last dose or end of study, whichever is earlier. Duration with median (min, max) in months: 3.32 (1.28, 29.31)"
        },
        {
          "measure": "Number of Participants With Treatment-Related Adverse Events (AEs)",
          "description": "A treatment-related AE was defined as any untoward medical occurrence in a clinical trial participant that was considered related to the investigational product. Any clinically significant changes in vital signs, physical examinations, and clinical laboratory tests that were considered related to the investigational product were recorded as treatment-related AEs.",
          "time_frame": "First dose of study drug until 37 days after last dose or end of study, whichever is earlier. Duration with median (min, max) in months: 3.32 (1.28, 29.31)"
        }
      ],
      "why_stopped": "Amgen business decision",
      "results_available": true,
      "detailed_results": {
        "resultsSection": {
          "participantFlowModule": {
            "preAssignmentDetails": "Of the planned 200 participants, 30 were enrolled. Of the 30 participants enrolled, 29 received investigational product. Due to early termination, participants were only enrolled into dose escalation AMG 596 monotherapy arms.",
            "recruitmentDetails": "Participants were enrolled from April 18, 2018 and last participant visit was August 28, 2021. Participants enrolled at 9 centers in United States, Australia, France, Germany, Netherlands, and Spain.",
            "groups": [
              {
                "id": "FG000",
                "title": "AMG 596 Monotherapy 4.5 mcg",
                "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG001",
                "title": "AMG 596 Monotherapy 15 mcg",
                "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG002",
                "title": "AMG 596 Monotherapy 45 mcg",
                "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG003",
                "title": "AMG 596 Monotherapy 150 mcg",
                "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG004",
                "title": "AMG596 Monotherapy 500 mcg",
                "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG005",
                "title": "AMG596 Monotherapy 1000 mcg",
                "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG006",
                "title": "AMG596 Monotherapy 1500 mcg",
                "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG007",
                "title": "AMG596 Monotherapy 3000 mcg",
                "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG008",
                "title": "AMG596 Monotherapy 6000 mcg",
                "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "FG009",
                "title": "AMG596 Monotherapy 1500/15 mcg",
                "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
              }
            ],
            "periods": [
              {
                "title": "Overall Study",
                "milestones": [
                  {
                    "type": "STARTED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "5"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "1"
                      }
                    ]
                  },
                  {
                    "type": "Received Investigational Product",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "5"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "1"
                      }
                    ]
                  },
                  {
                    "type": "COMPLETED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "0"
                      }
                    ]
                  },
                  {
                    "type": "NOT COMPLETED",
                    "achievements": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "4"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "5"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "1"
                      }
                    ]
                  }
                ],
                "dropWithdraws": [
                  {
                    "type": "Started Other Antitumor Therapy",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "0"
                      }
                    ]
                  },
                  {
                    "type": "Death",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "3"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "2"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "0"
                      }
                    ]
                  },
                  {
                    "type": "Withdrawal by Subject",
                    "reasons": [
                      {
                        "groupId": "FG000",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG001",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG002",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG003",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG004",
                        "numSubjects": "1"
                      },
                      {
                        "groupId": "FG005",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG006",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG007",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG008",
                        "numSubjects": "0"
                      },
                      {
                        "groupId": "FG009",
                        "numSubjects": "1"
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "baselineCharacteristicsModule": {
            "populationDescription": "Baseline data were collected for all enrolled participants.",
            "groups": [
              {
                "id": "BG000",
                "title": "AMG 596 Monotherapy 4.5 mcg",
                "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG001",
                "title": "AMG 596 Monotherapy 15 mcg",
                "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG002",
                "title": "AMG 596 Monotherapy 45 mcg",
                "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG003",
                "title": "AMG 596 Monotherapy 150 mcg",
                "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG004",
                "title": "AMG596 Monotherapy 500 mcg",
                "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG005",
                "title": "AMG596 Monotherapy 1000 mcg",
                "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG006",
                "title": "AMG596 Monotherapy 1500 mcg",
                "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG007",
                "title": "AMG596 Monotherapy 3000 mcg",
                "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG008",
                "title": "AMG596 Monotherapy 6000 mcg",
                "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
              },
              {
                "id": "BG009",
                "title": "AMG596 Monotherapy 1500/15 mcg",
                "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
              },
              {
                "id": "BG010",
                "title": "Total",
                "description": "Total of all reporting groups"
              }
            ],
            "denoms": [
              {
                "units": "Participants",
                "counts": [
                  {
                    "groupId": "BG000",
                    "value": "1"
                  },
                  {
                    "groupId": "BG001",
                    "value": "3"
                  },
                  {
                    "groupId": "BG002",
                    "value": "3"
                  },
                  {
                    "groupId": "BG003",
                    "value": "4"
                  },
                  {
                    "groupId": "BG004",
                    "value": "4"
                  },
                  {
                    "groupId": "BG005",
                    "value": "4"
                  },
                  {
                    "groupId": "BG006",
                    "value": "4"
                  },
                  {
                    "groupId": "BG007",
                    "value": "5"
                  },
                  {
                    "groupId": "BG008",
                    "value": "1"
                  },
                  {
                    "groupId": "BG009",
                    "value": "1"
                  },
                  {
                    "groupId": "BG010",
                    "value": "30"
                  }
                ]
              }
            ],
            "measures": [
              {
                "title": "Age, Categorical",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "<=18 years",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Between 18 and 65 years",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          },
                          {
                            "groupId": "BG001",
                            "value": "3"
                          },
                          {
                            "groupId": "BG002",
                            "value": "3"
                          },
                          {
                            "groupId": "BG003",
                            "value": "3"
                          },
                          {
                            "groupId": "BG004",
                            "value": "3"
                          },
                          {
                            "groupId": "BG005",
                            "value": "4"
                          },
                          {
                            "groupId": "BG006",
                            "value": "4"
                          },
                          {
                            "groupId": "BG007",
                            "value": "5"
                          },
                          {
                            "groupId": "BG008",
                            "value": "1"
                          },
                          {
                            "groupId": "BG009",
                            "value": "1"
                          },
                          {
                            "groupId": "BG010",
                            "value": "28"
                          }
                        ]
                      },
                      {
                        "title": ">=65 years",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "1"
                          },
                          {
                            "groupId": "BG004",
                            "value": "1"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "2"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Age, Continuous",
                "paramType": "MEAN",
                "dispersionType": "STANDARD_DEVIATION",
                "unitOfMeasure": "Years",
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "62.0",
                            "spread": "NA",
                            "comment": "Standard deviation cannot be calculated for a single participant."
                          },
                          {
                            "groupId": "BG001",
                            "value": "51.0",
                            "spread": "6.1"
                          },
                          {
                            "groupId": "BG002",
                            "value": "56.7",
                            "spread": "8.7"
                          },
                          {
                            "groupId": "BG003",
                            "value": "58.0",
                            "spread": "7.5"
                          },
                          {
                            "groupId": "BG004",
                            "value": "51.5",
                            "spread": "13.6"
                          },
                          {
                            "groupId": "BG005",
                            "value": "55.0",
                            "spread": "4.9"
                          },
                          {
                            "groupId": "BG006",
                            "value": "51.5",
                            "spread": "12.4"
                          },
                          {
                            "groupId": "BG007",
                            "value": "53.0",
                            "spread": "5.5"
                          },
                          {
                            "groupId": "BG008",
                            "value": "44.0",
                            "spread": "NA",
                            "comment": "Standard deviation cannot be calculated for a single participant."
                          },
                          {
                            "groupId": "BG009",
                            "value": "49.0",
                            "spread": "NA",
                            "comment": "Standard deviation cannot be calculated for a single participant."
                          },
                          {
                            "groupId": "BG010",
                            "value": "54.1",
                            "spread": "7.7"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Sex: Female, Male",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "Female",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          },
                          {
                            "groupId": "BG001",
                            "value": "2"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "2"
                          },
                          {
                            "groupId": "BG004",
                            "value": "1"
                          },
                          {
                            "groupId": "BG005",
                            "value": "1"
                          },
                          {
                            "groupId": "BG006",
                            "value": "1"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "1"
                          },
                          {
                            "groupId": "BG009",
                            "value": "1"
                          },
                          {
                            "groupId": "BG010",
                            "value": "10"
                          }
                        ]
                      },
                      {
                        "title": "Male",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "1"
                          },
                          {
                            "groupId": "BG002",
                            "value": "3"
                          },
                          {
                            "groupId": "BG003",
                            "value": "2"
                          },
                          {
                            "groupId": "BG004",
                            "value": "3"
                          },
                          {
                            "groupId": "BG005",
                            "value": "3"
                          },
                          {
                            "groupId": "BG006",
                            "value": "3"
                          },
                          {
                            "groupId": "BG007",
                            "value": "5"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "20"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Ethnicity (NIH/OMB)",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "Hispanic or Latino",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Not Hispanic or Latino",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          },
                          {
                            "groupId": "BG001",
                            "value": "3"
                          },
                          {
                            "groupId": "BG002",
                            "value": "3"
                          },
                          {
                            "groupId": "BG003",
                            "value": "4"
                          },
                          {
                            "groupId": "BG004",
                            "value": "3"
                          },
                          {
                            "groupId": "BG005",
                            "value": "4"
                          },
                          {
                            "groupId": "BG006",
                            "value": "4"
                          },
                          {
                            "groupId": "BG007",
                            "value": "5"
                          },
                          {
                            "groupId": "BG008",
                            "value": "1"
                          },
                          {
                            "groupId": "BG009",
                            "value": "1"
                          },
                          {
                            "groupId": "BG010",
                            "value": "29"
                          }
                        ]
                      },
                      {
                        "title": "Unknown or Not Reported",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "1"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "title": "Race (NIH/OMB)",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "classes": [
                  {
                    "categories": [
                      {
                        "title": "American Indian or Alaska Native",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Asian",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "1"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "1"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "2"
                          }
                        ]
                      },
                      {
                        "title": "Native Hawaiian or Other Pacific Islander",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Black or African American",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "White",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "1"
                          },
                          {
                            "groupId": "BG001",
                            "value": "2"
                          },
                          {
                            "groupId": "BG002",
                            "value": "3"
                          },
                          {
                            "groupId": "BG003",
                            "value": "4"
                          },
                          {
                            "groupId": "BG004",
                            "value": "3"
                          },
                          {
                            "groupId": "BG005",
                            "value": "3"
                          },
                          {
                            "groupId": "BG006",
                            "value": "4"
                          },
                          {
                            "groupId": "BG007",
                            "value": "2"
                          },
                          {
                            "groupId": "BG008",
                            "value": "1"
                          },
                          {
                            "groupId": "BG009",
                            "value": "1"
                          },
                          {
                            "groupId": "BG010",
                            "value": "24"
                          }
                        ]
                      },
                      {
                        "title": "More than one race",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "0"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "0"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "0"
                          }
                        ]
                      },
                      {
                        "title": "Unknown or Not Reported",
                        "measurements": [
                          {
                            "groupId": "BG000",
                            "value": "0"
                          },
                          {
                            "groupId": "BG001",
                            "value": "0"
                          },
                          {
                            "groupId": "BG002",
                            "value": "0"
                          },
                          {
                            "groupId": "BG003",
                            "value": "0"
                          },
                          {
                            "groupId": "BG004",
                            "value": "1"
                          },
                          {
                            "groupId": "BG005",
                            "value": "0"
                          },
                          {
                            "groupId": "BG006",
                            "value": "0"
                          },
                          {
                            "groupId": "BG007",
                            "value": "3"
                          },
                          {
                            "groupId": "BG008",
                            "value": "0"
                          },
                          {
                            "groupId": "BG009",
                            "value": "0"
                          },
                          {
                            "groupId": "BG010",
                            "value": "4"
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "outcomeMeasuresModule": {
            "outcomeMeasures": [
              {
                "type": "PRIMARY",
                "title": "Number of Participants With Dose-Limiting Toxicities (DLTs)",
                "description": "A DLT was any of the following occurring and regarded by the investigator as related to AMG 596. Hematological DLTs: absolute neutrophil count (ANC) \\<0.5\u00d710\\^9/L for \u22657 days, febrile neutropenia with ANC\\<0.5\u00d710\\^9/L and fever \u226538.5\u00b0C, platelets\\<50\u00d710\\^9/L\\>7 days or clinically significant bleeding. Non-hematological DLTs: any grade 4 non-hematological toxicity, any grade \u22653 non-hematological toxicity if nausea and vomiting, grade 3 non-hematologic toxicity lasting \\>3 days despite treatment, grade 3 fatigue wasn't classified as DLT, grade 3 acute kidney injury, grade 3 seizure, ataxia, encephalopathy, other grade 3 neurologic-related adverse events lasting \\>3 days despite treatment, neurologic-related adverse event leading to treatment interruption needing\\>1 week to resolve to grade\u22641, any grade 3 endocrinopathy that can't be controlled by hormonal replacement. Toxicity grading was graded using the Common Terminology Criteria for Adverse Events (CTCAE v4.0)",
                "populationDescription": "The DLT Evaluable Analysis Set included all participants in the 7-day on/7-day off dosing groups who completed 100% of planned doses and all participants in the 28-day on/14-day off dosing groups who completed 90% of planned doses.",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "timeFrame": "Up to 28 days",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          },
                          {
                            "groupId": "OG003",
                            "value": "0"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0"
                          },
                          {
                            "groupId": "OG005",
                            "value": "0"
                          },
                          {
                            "groupId": "OG006",
                            "value": "0"
                          },
                          {
                            "groupId": "OG007",
                            "value": "0"
                          },
                          {
                            "groupId": "OG008",
                            "value": "0"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "PRIMARY",
                "title": "Number of Participants With Treatment Emergent Adverse Events (TEAEs)",
                "description": "An adverse event (AE) was defined as any untoward medical occurrence in a clinical trial participant. A TEAE was any AE that begun or worsened after the initial dose of investigational product. Any clinically significant changes in vital signs, physical examinations, and clinical laboratory tests that begun or worsened after the initial dose of investigational product were recorded as TEAEs.",
                "populationDescription": "The safety analysis set included all participants who were enrolled and received at least 1 dose of AMG 596.",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "timeFrame": "First dose of study drug until 37 days after last dose or end of study, whichever is earlier. Duration with median (min, max) in months: 3.32 (1.28, 29.31)",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          },
                          {
                            "groupId": "OG003",
                            "value": "4"
                          },
                          {
                            "groupId": "OG004",
                            "value": "3"
                          },
                          {
                            "groupId": "OG005",
                            "value": "3"
                          },
                          {
                            "groupId": "OG006",
                            "value": "4"
                          },
                          {
                            "groupId": "OG007",
                            "value": "5"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "PRIMARY",
                "title": "Number of Participants With Treatment-Related Adverse Events (AEs)",
                "description": "A treatment-related AE was defined as any untoward medical occurrence in a clinical trial participant that was considered related to the investigational product. Any clinically significant changes in vital signs, physical examinations, and clinical laboratory tests that were considered related to the investigational product were recorded as treatment-related AEs.",
                "populationDescription": "The safety analysis set included all participants who were enrolled and received at least 1 dose of AMG 596.",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "timeFrame": "First dose of study drug until 37 days after last dose or end of study, whichever is earlier. Duration with median (min, max) in months: 3.32 (1.28, 29.31)",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "3"
                          },
                          {
                            "groupId": "OG005",
                            "value": "2"
                          },
                          {
                            "groupId": "OG006",
                            "value": "4"
                          },
                          {
                            "groupId": "OG007",
                            "value": "4"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Average Steady-state Concentration (Css) of Serum AMG 596",
                "populationDescription": "The pharmacokinetic (PK) analysis set contained all participants who received the investigational product and had available PK data for each timepoint.",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Full Range",
                "unitOfMeasure": "ng/mL",
                "timeFrame": "Cycle1 to Cycle2 (cycle=14 days in single participant cohorts,42 days in multiple participant cohorts):7-days on/7-days off dosing and 28-days on/14-days off dosing:pre-infusion,2,6,8,24,48hrs post-infusion start,0.5,2,4,8,24hrs post infusion end",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Cycle 1",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          },
                          {
                            "groupId": "OG003",
                            "value": "4"
                          },
                          {
                            "groupId": "OG004",
                            "value": "3"
                          },
                          {
                            "groupId": "OG005",
                            "value": "4"
                          },
                          {
                            "groupId": "OG006",
                            "value": "4"
                          },
                          {
                            "groupId": "OG007",
                            "value": "5"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.733",
                            "lowerLimit": "0.733",
                            "upperLimit": "0.733"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1.90",
                            "lowerLimit": "1.87",
                            "upperLimit": "1.93"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3.38",
                            "lowerLimit": "3.28",
                            "upperLimit": "3.47"
                          },
                          {
                            "groupId": "OG003",
                            "value": "9.53",
                            "lowerLimit": "2.98",
                            "upperLimit": "14.0"
                          },
                          {
                            "groupId": "OG004",
                            "value": "26.7",
                            "lowerLimit": "22.4",
                            "upperLimit": "29.8"
                          },
                          {
                            "groupId": "OG005",
                            "value": "67.1",
                            "lowerLimit": "45.9",
                            "upperLimit": "89.0"
                          },
                          {
                            "groupId": "OG006",
                            "value": "106",
                            "lowerLimit": "72.5",
                            "upperLimit": "136"
                          },
                          {
                            "groupId": "OG007",
                            "value": "180",
                            "lowerLimit": "103",
                            "upperLimit": "222"
                          },
                          {
                            "groupId": "OG008",
                            "value": "610",
                            "lowerLimit": "610",
                            "upperLimit": "610"
                          },
                          {
                            "groupId": "OG009",
                            "value": "19.4",
                            "lowerLimit": "19.4",
                            "upperLimit": "19.4"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Cycle 2",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "3"
                          },
                          {
                            "groupId": "OG002",
                            "value": "2"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "2"
                          },
                          {
                            "groupId": "OG005",
                            "value": "3"
                          },
                          {
                            "groupId": "OG006",
                            "value": "3"
                          },
                          {
                            "groupId": "OG007",
                            "value": "3"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.548",
                            "lowerLimit": "0.548",
                            "upperLimit": "0.548"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1.48",
                            "lowerLimit": "0.872",
                            "upperLimit": "2.51"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3.37",
                            "lowerLimit": "2.81",
                            "upperLimit": "3.93"
                          },
                          {
                            "groupId": "OG003",
                            "value": "11.4",
                            "lowerLimit": "6.91",
                            "upperLimit": "13.7"
                          },
                          {
                            "groupId": "OG004",
                            "value": "36.2",
                            "lowerLimit": "25.6",
                            "upperLimit": "46.9"
                          },
                          {
                            "groupId": "OG005",
                            "value": "74.3",
                            "lowerLimit": "25.0",
                            "upperLimit": "144"
                          },
                          {
                            "groupId": "OG006",
                            "value": "115",
                            "lowerLimit": "60.1",
                            "upperLimit": "157"
                          },
                          {
                            "groupId": "OG007",
                            "value": "194",
                            "lowerLimit": "148",
                            "upperLimit": "254"
                          },
                          {
                            "groupId": "OG008",
                            "value": "807",
                            "lowerLimit": "807",
                            "upperLimit": "807"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Area Under the Concentration-time Curve (AUC) for Serum AMG 596",
                "description": "There were insufficient evaluable samples collected for the determination of AUC.",
                "populationDescription": "The pharmacokinetic (PK) analysis set contained all participants who received the investigational product and had available PK data for each timepoint. 0 participants had evaluable data for the determination of AUC, therefore 0 participants were analyzed for this endpoint.",
                "reportingStatus": "POSTED",
                "timeFrame": "Cycle1 to Cycle2 (cycle=14 days in single participant cohorts,42 days in multiple participant cohorts):7-days on/7-days off dosing and 28-days on/14-days off dosing:pre-infusion,2,6,8,24,48hrs post-infusion start,0.5,2,4,8,24hrs post infusion end",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "0"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      },
                      {
                        "groupId": "OG003",
                        "value": "0"
                      },
                      {
                        "groupId": "OG004",
                        "value": "0"
                      },
                      {
                        "groupId": "OG005",
                        "value": "0"
                      },
                      {
                        "groupId": "OG006",
                        "value": "0"
                      },
                      {
                        "groupId": "OG007",
                        "value": "0"
                      },
                      {
                        "groupId": "OG008",
                        "value": "0"
                      },
                      {
                        "groupId": "OG009",
                        "value": "0"
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Clearance for Serum AMG 596",
                "description": "Clearance (CL) is calculated based on dose and AUC.",
                "populationDescription": "The pharmacokinetic (PK) analysis set contained all participants who received the investigational product and had available PK data for each timepoint.",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Full Range",
                "unitOfMeasure": "mcg/day/(hr*ng/mL)",
                "timeFrame": "Cycle1 to Cycle2 (cycle=14 days in single participant cohorts,42 days in multiple participant cohorts):7-days on/7-days off dosing and 28-days on/14-days off dosing:pre-infusion,2,6,8,24,48hrs post-infusion start,0.5,2,4,8,24hrs post infusion end",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "2"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "3"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "4"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Cycle 1",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "3"
                          },
                          {
                            "groupId": "OG005",
                            "value": "4"
                          },
                          {
                            "groupId": "OG006",
                            "value": "4"
                          },
                          {
                            "groupId": "OG007",
                            "value": "4"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.0324",
                            "lowerLimit": "0.0324",
                            "upperLimit": "0.0324"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.0116",
                            "lowerLimit": "0.0102",
                            "upperLimit": "0.0130"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.0172",
                            "lowerLimit": "0.0122",
                            "upperLimit": "0.0200"
                          },
                          {
                            "groupId": "OG003",
                            "value": "0.0207",
                            "lowerLimit": "0.0161",
                            "upperLimit": "0.0294"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0.0272",
                            "lowerLimit": "0.0244",
                            "upperLimit": "0.0309"
                          },
                          {
                            "groupId": "OG005",
                            "value": "0.0237",
                            "lowerLimit": "0.0188",
                            "upperLimit": "0.0322"
                          },
                          {
                            "groupId": "OG006",
                            "value": "0.0218",
                            "lowerLimit": "0.0171",
                            "upperLimit": "0.0308"
                          },
                          {
                            "groupId": "OG007",
                            "value": "0.0291",
                            "lowerLimit": "0.0197",
                            "upperLimit": "0.0464"
                          },
                          {
                            "groupId": "OG008",
                            "value": "0.0146",
                            "lowerLimit": "0.0146",
                            "upperLimit": "0.0146"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0.158",
                            "lowerLimit": "0.158",
                            "upperLimit": "0.158"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Cycle 2",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0"
                          },
                          {
                            "groupId": "OG005",
                            "value": "1"
                          },
                          {
                            "groupId": "OG006",
                            "value": "2"
                          },
                          {
                            "groupId": "OG007",
                            "value": "1"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.0469",
                            "lowerLimit": "0.0469",
                            "upperLimit": "0.0469"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.0175",
                            "lowerLimit": "0.00910",
                            "upperLimit": "0.0259"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.0232",
                            "lowerLimit": "0.0232",
                            "upperLimit": "0.0232"
                          },
                          {
                            "groupId": "OG003",
                            "value": "0.0228",
                            "lowerLimit": "0.0163",
                            "upperLimit": "0.0309"
                          },
                          {
                            "groupId": "OG005",
                            "value": "0.0256",
                            "lowerLimit": "0.0256",
                            "upperLimit": "0.0256"
                          },
                          {
                            "groupId": "OG006",
                            "value": "0.0161",
                            "lowerLimit": "0.0147",
                            "upperLimit": "0.0175"
                          },
                          {
                            "groupId": "OG007",
                            "value": "0.0245",
                            "lowerLimit": "0.0245",
                            "upperLimit": "0.0245"
                          },
                          {
                            "groupId": "OG008",
                            "value": "0.0113",
                            "lowerLimit": "0.0113",
                            "upperLimit": "0.0113"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Apparent Volume of Distribution at Steady-State for Serum AMG 596",
                "description": "The formula for volume of distribution is dose/concentration. For this study, the dose is measured in mcg/day and concentration is measure as ng/mL resulting in units of mcg/day/(ng/mL) for volume of distribution.",
                "populationDescription": "The pharmacokinetic (PK) analysis set contained all participants who received the investigational product and had available PK data for each timepoint.",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Full Range",
                "unitOfMeasure": "mcg/day/(ng/mL)",
                "timeFrame": "Cycle1 to Cycle2 (cycle=14 days in single participant cohorts,42 days in multiple participant cohorts):7-days on/7-days off dosing and 28-days on/14-days off dosing:pre-infusion,2,6,8,24,48hrs post-infusion start,0.5,2,4,8,24hrs post infusion end",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "2"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "3"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "4"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Cycle 1",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "3"
                          },
                          {
                            "groupId": "OG005",
                            "value": "4"
                          },
                          {
                            "groupId": "OG006",
                            "value": "4"
                          },
                          {
                            "groupId": "OG007",
                            "value": "4"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.269",
                            "lowerLimit": "0.269",
                            "upperLimit": "0.269"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.0961",
                            "lowerLimit": "0.0637",
                            "upperLimit": "0.128"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.173",
                            "lowerLimit": "0.125",
                            "upperLimit": "0.213"
                          },
                          {
                            "groupId": "OG003",
                            "value": "0.247",
                            "lowerLimit": "0.198",
                            "upperLimit": "0.325"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0.200",
                            "lowerLimit": "0.155",
                            "upperLimit": "0.280"
                          },
                          {
                            "groupId": "OG005",
                            "value": "0.212",
                            "lowerLimit": "0.109",
                            "upperLimit": "0.278"
                          },
                          {
                            "groupId": "OG006",
                            "value": "0.205",
                            "lowerLimit": "0.155",
                            "upperLimit": "0.268"
                          },
                          {
                            "groupId": "OG007",
                            "value": "0.269",
                            "lowerLimit": "0.185",
                            "upperLimit": "0.387"
                          },
                          {
                            "groupId": "OG008",
                            "value": "0.166",
                            "lowerLimit": "0.166",
                            "upperLimit": "0.166"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1.61",
                            "lowerLimit": "1.61",
                            "upperLimit": "1.61"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Cycle 2",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0"
                          },
                          {
                            "groupId": "OG005",
                            "value": "1"
                          },
                          {
                            "groupId": "OG006",
                            "value": "2"
                          },
                          {
                            "groupId": "OG007",
                            "value": "1"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0.289",
                            "lowerLimit": "0.289",
                            "upperLimit": "0.289"
                          },
                          {
                            "groupId": "OG001",
                            "value": "0.162",
                            "lowerLimit": "0.0929",
                            "upperLimit": "0.232"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0.246",
                            "lowerLimit": "0.246",
                            "upperLimit": "0.246"
                          },
                          {
                            "groupId": "OG003",
                            "value": "0.242",
                            "lowerLimit": "0.158",
                            "upperLimit": "0.354"
                          },
                          {
                            "groupId": "OG005",
                            "value": "0.223",
                            "lowerLimit": "0.223",
                            "upperLimit": "0.223"
                          },
                          {
                            "groupId": "OG006",
                            "value": "0.140",
                            "lowerLimit": "0.0836",
                            "upperLimit": "0.196"
                          },
                          {
                            "groupId": "OG007",
                            "value": "0.235",
                            "lowerLimit": "0.235",
                            "upperLimit": "0.235"
                          },
                          {
                            "groupId": "OG008",
                            "value": "0.115",
                            "lowerLimit": "0.115",
                            "upperLimit": "0.115"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Terminal Half-life (t1/2) Associated With Lambda z (\u03bbz) for Serum AMG 596",
                "populationDescription": "The pharmacokinetic (PK) analysis set contained all participants who received the investigational product and had available PK data for each timepoint.",
                "reportingStatus": "POSTED",
                "paramType": "MEAN",
                "dispersionType": "Full Range",
                "unitOfMeasure": "Hours",
                "timeFrame": "Cycle1 to Cycle2 (cycle=14 days in single participant cohorts,42 days in multiple participant cohorts):7-days on/7-days off dosing and 28-days on/14-days off dosing:pre-infusion,2,6,8,24,48hrs post-infusion start,0.5,2,4,8,24hrs post infusion end",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "2"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "3"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "4"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "title": "Cycle 1",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "3"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "3"
                          },
                          {
                            "groupId": "OG005",
                            "value": "4"
                          },
                          {
                            "groupId": "OG006",
                            "value": "4"
                          },
                          {
                            "groupId": "OG007",
                            "value": "4"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "1"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "5.75",
                            "lowerLimit": "5.75",
                            "upperLimit": "5.75"
                          },
                          {
                            "groupId": "OG001",
                            "value": "5.59",
                            "lowerLimit": "4.34",
                            "upperLimit": "6.84"
                          },
                          {
                            "groupId": "OG002",
                            "value": "6.98",
                            "lowerLimit": "6.42",
                            "upperLimit": "7.39"
                          },
                          {
                            "groupId": "OG003",
                            "value": "8.44",
                            "lowerLimit": "7.66",
                            "upperLimit": "9.10"
                          },
                          {
                            "groupId": "OG004",
                            "value": "5.02",
                            "lowerLimit": "4.37",
                            "upperLimit": "6.29"
                          },
                          {
                            "groupId": "OG005",
                            "value": "6.16",
                            "lowerLimit": "3.96",
                            "upperLimit": "7.49"
                          },
                          {
                            "groupId": "OG006",
                            "value": "6.67",
                            "lowerLimit": "5.31",
                            "upperLimit": "8.51"
                          },
                          {
                            "groupId": "OG007",
                            "value": "6.54",
                            "lowerLimit": "5.77",
                            "upperLimit": "7.23"
                          },
                          {
                            "groupId": "OG008",
                            "value": "7.90",
                            "lowerLimit": "7.90",
                            "upperLimit": "7.90"
                          },
                          {
                            "groupId": "OG009",
                            "value": "7.04",
                            "lowerLimit": "7.04",
                            "upperLimit": "7.04"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "title": "Cycle 2",
                    "denoms": [
                      {
                        "units": "Participants",
                        "counts": [
                          {
                            "groupId": "OG000",
                            "value": "1"
                          },
                          {
                            "groupId": "OG001",
                            "value": "2"
                          },
                          {
                            "groupId": "OG002",
                            "value": "1"
                          },
                          {
                            "groupId": "OG003",
                            "value": "3"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0"
                          },
                          {
                            "groupId": "OG005",
                            "value": "1"
                          },
                          {
                            "groupId": "OG006",
                            "value": "2"
                          },
                          {
                            "groupId": "OG007",
                            "value": "1"
                          },
                          {
                            "groupId": "OG008",
                            "value": "1"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0"
                          }
                        ]
                      }
                    ],
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "4.27",
                            "lowerLimit": "4.27",
                            "upperLimit": "4.27"
                          },
                          {
                            "groupId": "OG001",
                            "value": "6.64",
                            "lowerLimit": "6.21",
                            "upperLimit": "7.07"
                          },
                          {
                            "groupId": "OG002",
                            "value": "7.33",
                            "lowerLimit": "7.33",
                            "upperLimit": "7.33"
                          },
                          {
                            "groupId": "OG003",
                            "value": "7.23",
                            "lowerLimit": "6.72",
                            "upperLimit": "7.94"
                          },
                          {
                            "groupId": "OG005",
                            "value": "6.05",
                            "lowerLimit": "6.05",
                            "upperLimit": "6.05"
                          },
                          {
                            "groupId": "OG006",
                            "value": "5.87",
                            "lowerLimit": "3.95",
                            "upperLimit": "7.79"
                          },
                          {
                            "groupId": "OG007",
                            "value": "6.64",
                            "lowerLimit": "6.64",
                            "upperLimit": "6.64"
                          },
                          {
                            "groupId": "OG008",
                            "value": "7.05",
                            "lowerLimit": "7.05",
                            "upperLimit": "7.05"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Number of Participants With an Objective Response (OR) Per Modified Response Assessment in Neuro-Oncology Criteria (RANO) Criteria With AMG 596 Monotherapy",
                "description": "Objective response was defined as the number of participants with complete response (CR) or partial response (PR) per modified RANO criteria. CR per modified RANO: disappearance of all enhancing disease, no new lesions, stable or improved T2-weighted fluid-attenuated inversion recovery (T2/FLAIR), no more than physiological steroids, clinically stable or improved, disappearance confirmed with follow-up scans after \u22654 weeks. PR per modified RANO: \u226550% decrease in the sum of perpendicular diameters of enhancing disease from baseline, stable or improved T2/FLAIR, stable or decreased steroid dose, clinically stable or improved, decrease confirmed with follow up scan after \u2265 4 weeks.",
                "populationDescription": "The RANO Evaluable Analysis set included all participants that were enrolled and received at least one administration of AMG 596 and who had at least one measurable lesion identified by the Principal Investigator at baseline.",
                "reportingStatus": "POSTED",
                "paramType": "COUNT_OF_PARTICIPANTS",
                "unitOfMeasure": "Participants",
                "timeFrame": "Baseline up to 12 Months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "3"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "0"
                          },
                          {
                            "groupId": "OG001",
                            "value": "1"
                          },
                          {
                            "groupId": "OG002",
                            "value": "0"
                          },
                          {
                            "groupId": "OG003",
                            "value": "0"
                          },
                          {
                            "groupId": "OG004",
                            "value": "0"
                          },
                          {
                            "groupId": "OG005",
                            "value": "0"
                          },
                          {
                            "groupId": "OG006",
                            "value": "0"
                          },
                          {
                            "groupId": "OG007",
                            "value": "0"
                          },
                          {
                            "groupId": "OG008",
                            "value": "0"
                          },
                          {
                            "groupId": "OG009",
                            "value": "0"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Time to Response With AMG 596 Monotherapy",
                "description": "Time to response was calculated as the number of months from the date of first administration of AMG 596 to the date of confirmation of first objective response per magnetic resonance imaging (MRI) scan. If a participant did not respond, time to response was censored at the date of the last evaluable response assessment.",
                "populationDescription": "The safety analysis set included all participants who were enrolled and received at least 1 dose of AMG 596. Only participants with OR were used for this analysis.",
                "reportingStatus": "POSTED",
                "paramType": "MEDIAN",
                "dispersionType": "80% Confidence Interval",
                "unitOfMeasure": "Months",
                "timeFrame": "Up to 12 months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "1"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      },
                      {
                        "groupId": "OG003",
                        "value": "0"
                      },
                      {
                        "groupId": "OG004",
                        "value": "0"
                      },
                      {
                        "groupId": "OG005",
                        "value": "0"
                      },
                      {
                        "groupId": "OG006",
                        "value": "0"
                      },
                      {
                        "groupId": "OG007",
                        "value": "0"
                      },
                      {
                        "groupId": "OG008",
                        "value": "0"
                      },
                      {
                        "groupId": "OG009",
                        "value": "0"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG001",
                            "value": "7.0",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant with evaluable data, therefore lower and upper confidence intervals could not be calculated."
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Response Duration With AMG 596 Monotherapy",
                "description": "Response duration was analysed as the number of months between the first tumor response assessment of an OR (PR or CR) which is subsequently confirmed to the time of the first tumor response assessment of progressive disease or death if due to disease progression.",
                "populationDescription": "The safety analysis set included all participants who were enrolled and received at least 1 dose of AMG 596. Only participants with OR were used for this analysis.",
                "reportingStatus": "POSTED",
                "paramType": "MEDIAN",
                "dispersionType": "80% Confidence Interval",
                "unitOfMeasure": "Months",
                "timeFrame": "Up to 30 months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "0"
                      },
                      {
                        "groupId": "OG001",
                        "value": "1"
                      },
                      {
                        "groupId": "OG002",
                        "value": "0"
                      },
                      {
                        "groupId": "OG003",
                        "value": "0"
                      },
                      {
                        "groupId": "OG004",
                        "value": "0"
                      },
                      {
                        "groupId": "OG005",
                        "value": "0"
                      },
                      {
                        "groupId": "OG006",
                        "value": "0"
                      },
                      {
                        "groupId": "OG007",
                        "value": "0"
                      },
                      {
                        "groupId": "OG008",
                        "value": "0"
                      },
                      {
                        "groupId": "OG009",
                        "value": "0"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG001",
                            "value": "27.9",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant with evaluable data, therefore lower and upper confidence intervals could not be calculated."
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Time to Progression (TTP) With AMG 596 Monotherapy",
                "description": "The TTP was calculated as the time from the date of first dose of AMG 596 until the date of diagnosis of progression of tumor. Participants who did not have progression were censored at the last radiological non-missing evaluable tumor assessment date.",
                "populationDescription": "The safety analysis set included all participants who were enrolled and received at least 1 dose of AMG 596",
                "reportingStatus": "POSTED",
                "paramType": "MEDIAN",
                "dispersionType": "80% Confidence Interval",
                "unitOfMeasure": "Months",
                "timeFrame": "Up to 12 Months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2.1",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant in the treatment arm, therefore confidence intervals cannot be calculated."
                          },
                          {
                            "groupId": "OG001",
                            "value": "1.9",
                            "lowerLimit": "0.7",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG002",
                            "value": "1.9",
                            "lowerLimit": "1.2",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG003",
                            "value": "2.6",
                            "lowerLimit": "2.4",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG004",
                            "value": "1.2",
                            "lowerLimit": "0.1",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG005",
                            "value": "1.7",
                            "lowerLimit": "1.0",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG006",
                            "value": "2.4",
                            "lowerLimit": "1.2",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG007",
                            "value": "7.0",
                            "lowerLimit": "1.3",
                            "upperLimit": "NA",
                            "comment": "Values are not evaluable as the upper limit was not reached."
                          },
                          {
                            "groupId": "OG008",
                            "value": "5.3",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant in the treatment arm, therefore confidence intervals cannot be calculated."
                          },
                          {
                            "groupId": "OG009",
                            "value": "2.6",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant in the treatment arm, therefore confidence intervals cannot be calculated."
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "type": "SECONDARY",
                "title": "Progression-free Survival (PFS) With AMG 596 Monotherapy",
                "description": "The PFS was calculated as the time from the date of first dose of AMG 596 until the date of diagnosis of progression of tumor, or date of death, whichever was earlier.",
                "populationDescription": "The safety analysis set included all participants who were enrolled and received at least 1 dose of AMG 596.",
                "reportingStatus": "POSTED",
                "paramType": "MEDIAN",
                "dispersionType": "80% Confidence Interval",
                "unitOfMeasure": "Months",
                "timeFrame": "Up to 12 months",
                "groups": [
                  {
                    "id": "OG000",
                    "title": "AMG 596 Monotherapy 4.5 mcg",
                    "description": "Participants received 4.5 mcg of AMG 596 by continuous intravenous (cIV) infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG001",
                    "title": "AMG 596 Monotherapy 15 mcg",
                    "description": "The first participant received 15 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied. The remaining 2 participants received 15 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG002",
                    "title": "AMG 596 Monotherapy 45 mcg",
                    "description": "Participants received 45 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG003",
                    "title": "AMG 596 Monotherapy 150 mcg",
                    "description": "Participants received 150 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG004",
                    "title": "AMG596 Monotherapy 500 mcg",
                    "description": "Participants received 500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG005",
                    "title": "AMG596 Monotherapy 1000 mcg",
                    "description": "Participants received 1000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG006",
                    "title": "AMG596 Monotherapy 1500 mcg",
                    "description": "Participants received 1500 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG007",
                    "title": "AMG596 Monotherapy 3000 mcg",
                    "description": "Participants received 3000 mcg of AMG 596 by cIV infusion on a 28-days on/14-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG008",
                    "title": "AMG596 Monotherapy 6000 mcg",
                    "description": "Participants received 6000 mcg of AMG 596 by cIV infusion on a 7-days on/7-days off dosing schedule until treatment discontinuation criteria were applied."
                  },
                  {
                    "id": "OG009",
                    "title": "AMG596 Monotherapy 1500/15 mcg",
                    "description": "The participant was enrolled into AMG 596 Monotherapy 15 mcg cIV infusion arm but received an overdose (1500 mcg). Based on Food and Drug Administration recommendation, the participant received 1500 mcg/day during Week 1, followed by 15 mcg/day during Weeks 2 to 4, followed by a 2-week break."
                  }
                ],
                "denoms": [
                  {
                    "units": "Participants",
                    "counts": [
                      {
                        "groupId": "OG000",
                        "value": "1"
                      },
                      {
                        "groupId": "OG001",
                        "value": "3"
                      },
                      {
                        "groupId": "OG002",
                        "value": "3"
                      },
                      {
                        "groupId": "OG003",
                        "value": "4"
                      },
                      {
                        "groupId": "OG004",
                        "value": "3"
                      },
                      {
                        "groupId": "OG005",
                        "value": "4"
                      },
                      {
                        "groupId": "OG006",
                        "value": "4"
                      },
                      {
                        "groupId": "OG007",
                        "value": "5"
                      },
                      {
                        "groupId": "OG008",
                        "value": "1"
                      },
                      {
                        "groupId": "OG009",
                        "value": "1"
                      }
                    ]
                  }
                ],
                "classes": [
                  {
                    "categories": [
                      {
                        "measurements": [
                          {
                            "groupId": "OG000",
                            "value": "2.1",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant in the treatment arm, therefore confidence intervals cannot be calculated."
                          },
                          {
                            "groupId": "OG001",
                            "value": "1.9",
                            "lowerLimit": "0.7",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG002",
                            "value": "1.9",
                            "lowerLimit": "1.2",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG003",
                            "value": "2.6",
                            "lowerLimit": "2.4",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG004",
                            "value": "1.2",
                            "lowerLimit": "0.1",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG005",
                            "value": "1.7",
                            "lowerLimit": "1.0",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG006",
                            "value": "2.4",
                            "lowerLimit": "1.2",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG007",
                            "value": "5.8",
                            "lowerLimit": "1.3",
                            "upperLimit": "NA",
                            "comment": "Upper confidence limit could not be calculated due to the low number of events reported."
                          },
                          {
                            "groupId": "OG008",
                            "value": "5.3",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant in the treatment arm, therefore confidence intervals cannot be calculated."
                          },
                          {
                            "groupId": "OG009",
                            "value": "2.6",
                            "lowerLimit": "NA",
                            "upperLimit": "NA",
                            "comment": "Only 1 participant in the treatment arm, therefore confidence intervals cannot be calculated."
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Mortality duration with median (min, max) in months: 4.27 (0.20, 35.48). Adverse Event duration with median (min, max) in months: 3.32 (1.28, 29.31).",
            "description": "Serious and Other Adverse Events were collected for all participants who received at least one dose of study drug. All Cause Mortality was collected for all enrolled participants.",
            "eventGroups": [
              {
                "id": "EG000",
                "title": "AMG596 4.5 mcg",
                "description": "AMG596 4.5 mcg/day 7 Day cIV",
                "deathsNumAffected": 0,
                "deathsNumAtRisk": 1,
                "seriousNumAffected": 0,
                "seriousNumAtRisk": 1,
                "otherNumAffected": 1,
                "otherNumAtRisk": 1
              },
              {
                "id": "EG001",
                "title": "AMG596 15 mcg",
                "description": "AMG596 15 mcg/day 7/28 Day cIV",
                "deathsNumAffected": 1,
                "deathsNumAtRisk": 3,
                "seriousNumAffected": 3,
                "seriousNumAtRisk": 3,
                "otherNumAffected": 3,
                "otherNumAtRisk": 3
              },
              {
                "id": "EG002",
                "title": "AMG596 45 mcg",
                "description": "AMG596 45 mcg/day 28 Day cIV",
                "deathsNumAffected": 1,
                "deathsNumAtRisk": 3,
                "seriousNumAffected": 1,
                "seriousNumAtRisk": 3,
                "otherNumAffected": 3,
                "otherNumAtRisk": 3
              },
              {
                "id": "EG003",
                "title": "AMG596 150 mcg",
                "description": "AMG596 150 mcg/day 28 Day cIV",
                "deathsNumAffected": 2,
                "deathsNumAtRisk": 4,
                "seriousNumAffected": 3,
                "seriousNumAtRisk": 4,
                "otherNumAffected": 4,
                "otherNumAtRisk": 4
              },
              {
                "id": "EG004",
                "title": "AMG596 500 mcg",
                "description": "AMG596 500 mcg/day 28 Day cIV",
                "deathsNumAffected": 2,
                "deathsNumAtRisk": 4,
                "seriousNumAffected": 2,
                "seriousNumAtRisk": 3,
                "otherNumAffected": 3,
                "otherNumAtRisk": 3
              },
              {
                "id": "EG005",
                "title": "AMG596 1000 mcg",
                "description": "AMG596 1000 mcg/day 28 Day cIV",
                "deathsNumAffected": 3,
                "deathsNumAtRisk": 4,
                "seriousNumAffected": 2,
                "seriousNumAtRisk": 4,
                "otherNumAffected": 3,
                "otherNumAtRisk": 4
              },
              {
                "id": "EG006",
                "title": "AMG596 1500 mcg",
                "description": "AMG596 1500 mcg/day 28 Day cIV",
                "deathsNumAffected": 1,
                "deathsNumAtRisk": 4,
                "seriousNumAffected": 3,
                "seriousNumAtRisk": 4,
                "otherNumAffected": 4,
                "otherNumAtRisk": 4
              },
              {
                "id": "EG007",
                "title": "AMG596 3000 mcg",
                "description": "AMG596 3000 mcg/day 28 Day cIV",
                "deathsNumAffected": 2,
                "deathsNumAtRisk": 5,
                "seriousNumAffected": 3,
                "seriousNumAtRisk": 5,
                "otherNumAffected": 5,
                "otherNumAtRisk": 5
              },
              {
                "id": "EG008",
                "title": "AMG596 6000 mcg",
                "description": "AMG596 6000 mcg/day 28 Day cIV",
                "deathsNumAffected": 0,
                "deathsNumAtRisk": 1,
                "seriousNumAffected": 1,
                "seriousNumAtRisk": 1,
                "otherNumAffected": 1,
                "otherNumAtRisk": 1
              },
              {
                "id": "EG009",
                "title": "AMG596 1500/15 mcg",
                "description": "AMG596 1500/15 mcg/day 28 Day cIV",
                "deathsNumAffected": 0,
                "deathsNumAtRisk": 1,
                "seriousNumAffected": 1,
                "seriousNumAtRisk": 1,
                "otherNumAffected": 1,
                "otherNumAtRisk": 1
              }
            ],
            "seriousEvents": [
              {
                "term": "Tachycardia",
                "organSystem": "Cardiac disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vertigo",
                "organSystem": "Ear and labyrinth disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Nausea",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vomiting",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Fatigue",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "General physical health deterioration",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hyperthermia",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pyrexia",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Catheter site infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Device related infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pneumonia",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vascular access site infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vascular device infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Wound infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Shunt malfunction",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Subdural haematoma",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vascular access complication",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Glioblastoma",
                "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Glioblastoma multiforme",
                "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Aphasia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Cerebrovascular accident",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Depressed level of consciousness",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Headache",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hydrocephalus",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Seizure",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Somnolence",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Syncope",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Anxiety",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hiccups",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Rash maculo-papular",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypotension",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              }
            ],
            "otherEvents": [
              {
                "term": "Anaemia",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Leukopenia",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Lymphopenia",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Neutropenia",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Normocytic anaemia",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Thrombocytopenia",
                "organSystem": "Blood and lymphatic system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Tachycardia",
                "organSystem": "Cardiac disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vertigo",
                "organSystem": "Ear and labyrinth disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Cushingoid",
                "organSystem": "Endocrine disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Chalazion",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Eye disorder",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Lacrimation increased",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Visual acuity reduced",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Visual impairment",
                "organSystem": "Eye disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Abdominal pain",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Anal incontinence",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Constipation",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Diarrhoea",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 2,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dyspepsia",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypoaesthesia oral",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Nausea",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vomiting",
                "organSystem": "Gastrointestinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Asthenia",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Catheter site thrombosis",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Chest pain",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Chills",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Device related thrombosis",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Fatigue",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 3,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 3,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Gait disturbance",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Malaise",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Mucosal inflammation",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Oedema",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pyrexia",
                "organSystem": "General disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hyperbilirubinaemia",
                "organSystem": "Hepatobiliary disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Cytokine release syndrome",
                "organSystem": "Immune system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Immune system disorder",
                "organSystem": "Immune system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Bronchitis",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Catheter site infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Device related infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Herpes zoster",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Nasopharyngitis",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pneumonia",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Sinusitis",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Skin infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Urinary tract infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Urinary tract infection bacterial",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Urinary tract infection staphylococcal",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vascular device infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Viral infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Wound infection",
                "organSystem": "Infections and infestations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Contusion",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Vascular access complication",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Wound haemorrhage",
                "organSystem": "Injury, poisoning and procedural complications",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Alanine aminotransferase abnormal",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Alanine aminotransferase increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 2,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Aspartate aminotransferase abnormal",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Aspartate aminotransferase increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 2,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Blood alkaline phosphatase increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Blood bilirubin increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Blood creatine phosphokinase increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Blood creatinine increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "C-reactive protein increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "CD4 lymphocytes decreased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Interleukin level increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Lipase increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Lymphocyte count abnormal",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Lymphocyte count decreased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "White blood cell count decreased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "White blood cell count increased",
                "organSystem": "Investigations",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Decreased appetite",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dehydration",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dyslipidaemia",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hyperchloraemia",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hyperkalaemia",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypoalbuminaemia",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypokalaemia",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 2,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypouricaemia",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Metabolic disorder",
                "organSystem": "Metabolism and nutrition disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Arthralgia",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Back pain",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Muscular weakness",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 2,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Myalgia",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Neck pain",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pain in extremity",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pain in jaw",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Tenosynovitis",
                "organSystem": "Musculoskeletal and connective tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Amnesia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Aphasia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Ataxia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Balance disorder",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Brain oedema",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Cognitive disorder",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Depressed level of consciousness",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dizziness",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dysarthria",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dyskinesia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dysmetria",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Epilepsy",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Headache",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 3,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 4,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hemianopia homonymous",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hemiparesis",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hydrocephalus",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypersomnia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypoaesthesia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypokinesia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Language disorder",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Lethargy",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Memory impairment",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Neuropathy peripheral",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Paraesthesia",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pyramidal tract syndrome",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Seizure",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 2,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Somnolence",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 2,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Syncope",
                "organSystem": "Nervous system disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Device malfunction",
                "organSystem": "Product Issues",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Anxiety",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Bradyphrenia",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Confusional state",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Depressed mood",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Depression",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Disorientation",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Insomnia",
                "organSystem": "Psychiatric disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Acute kidney injury",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Bladder spasm",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Haematuria",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Polyuria",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Urinary incontinence",
                "organSystem": "Renal and urinary disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Atelectasis",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Cough",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dysphonia",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hiccups",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypoxia",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Oropharyngeal pain",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pleural effusion",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pleuritic pain",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Tachypnoea",
                "organSystem": "Respiratory, thoracic and mediastinal disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Alopecia",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 1,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Blister",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dermatitis acneiform",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Dry skin",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Erythema",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Onychoclasis",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Pruritus",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Purpura",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Rash",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 2,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Rash macular",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Rash maculo-papular",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Skin irritation",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Skin ulcer",
                "organSystem": "Skin and subcutaneous tissue disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Haematoma",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hot flush",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypertension",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 1,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Hypotension",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Phlebitis superficial",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Thrombophlebitis",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 0,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              },
              {
                "term": "Thrombosis",
                "organSystem": "Vascular disorders",
                "sourceVocabulary": "MedDRA 24.0",
                "assessmentType": "SYSTEMATIC_ASSESSMENT",
                "stats": [
                  {
                    "groupId": "EG000",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG001",
                    "numAffected": 1,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG002",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG003",
                    "numAffected": 1,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG004",
                    "numAffected": 0,
                    "numAtRisk": 3
                  },
                  {
                    "groupId": "EG005",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG006",
                    "numAffected": 0,
                    "numAtRisk": 4
                  },
                  {
                    "groupId": "EG007",
                    "numAffected": 1,
                    "numAtRisk": 5
                  },
                  {
                    "groupId": "EG008",
                    "numAffected": 0,
                    "numAtRisk": 1
                  },
                  {
                    "groupId": "EG009",
                    "numAffected": 0,
                    "numAtRisk": 1
                  }
                ]
              }
            ]
          },
          "moreInfoModule": {
            "limitationsAndCaveats": {
              "description": "The study was terminated early. Therefore, a smaller number of participants than planned were enrolled and analysed."
            },
            "certainAgreement": {
              "piSponsorEmployee": false,
              "restrictionType": "OTHER",
              "restrictiveAgreement": true,
              "otherDetails": "The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication."
            },
            "pointOfContact": {
              "title": "Study Director",
              "organization": "Amgen Inc.",
              "email": "medinfo@amgen.com",
              "phone": "866-572-6436"
            }
          }
        }
      }
    }
  ],
  "metadata": {
    "timestamp": "2025-07-29T10:44:13.915796",
    "query": {
      "disease": "glioblastoma",
      "target": "EGFR"
    },
    "version": "1.0"
  }
}